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Abstract
Management of metabolic syndrome (MetS) may be enhanced by promoting patient
engagement. Training health care providers in the conceptual and practical application of
integrative patient centered care tools may promote patient lifestyle behaviors for better
management of MetS. The purpose of this quantitative quasi-experimental study was to
assess the impact of training providers in integrative patient centered care for patients
with MetS. The biopsychosocial construct provided the conceptual framework for the
study. Two groups of physicians were included; one received training in an integrative
model (IM) while the second received no training and provided usual care (UC).
Following training, patient disease biometrics and medication adherence were monitored
for approximately four months. Due to a diminished sample size in the completer data
set, an intention to treat (ITT) data set was created with baseline values brought forward.
In the ITT set, BMI decreased significantly (p=0.005, d=0.18) with each group over time:
(IM: 32.9 ± 7.3 Kg/m2 to 31.6 ± 6.8 Kg/m2) and (UC: 32.1 ± 6.7 to 31.5 ± 6.3 Kg/m2).
However, there were no statistically significant differences between these two groups’
measures. In the completer set, BMI decreased significantly (p < 0.05, d=0.18) over time
with the IM group, but not the UC group: (IM: 35.14 ± 7.9 Kg/m2 to 33.65* ± 7.62
Kg/m2) and (UC: 32.4 ± 6.62 Kg/m2 and (32.4 ± 6.5 Kg/m2); indicating a possible
relationship between the intervention training (IM) and improved health outcomes. Thus,
providers are assisting patients with important lifestyle choices to better manage MetS,
potentially leading to social change around improved patient health care behaviors and
advancement in providers’ patient centered practices.
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Chapter 1: Introduction
Understanding the impact of patient engagement on health outcomes of chronic
disease patients is of critical interest due to escalating health care costs and an epidemic
of chronic disease in the United States. The Centers for Disease Control and Prevention
(CDC, 2011) stated the rates of chronic diseases such as obesity, cardiovascular disease,
stroke, and cancer are increasing and account for 75% of the two trillion dollars spent on
health care. This spending makes chronic disease the leading factor in current health care
expenditures in front of technology, prescription drugs, and administrative costs (CDC,
2011; Kaiser, 2012). To prevent chronic disease, researchers should examine the risk
factors and how to mitigate them. Metabolic syndrome (MetS) is diagnosed in a person
with three or more symptoms or precursors to chronic diseases such as cardiovascular
disease, type 2 diabetes, and stroke (Dickerson, Smith, McNeal, & Ory, 2011; Ma & Zhu,
2013). The symptoms include obesity, hyperglycemia, low cholesterol high-density
lipoprotein (HDL), and high triglycerides or hyperlipidemia (Burghen, 2005; Ma & Zhu,
2013). Dagogo-Jack, Egbuonu, and Edeoga (2010) indicated that health care providers
should start chronic disease intervention treatment at the onset of MetS or before to
decrease the cumulative effects of associated symptoms.
Impact of Patient Engagement
Even though there is abundant research on MetS, there is a gap in best practices
on successful ways to treat and prevent these symptoms (Appel, Jones, & KennedyMalone, 2004; Burghen, 2005; Dickerson et al., 2011; Ma & Zhu, 2013). There is limited
research on the link between MetS treatment approaches such as integrative patient
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centered care and how providers are or are not taught to interact with their patients.
Recent research on combinations of factors indicated further study due to protocolspecific limitations (Ampt et al., 2009; Brady, Solomon, Neu, Siberry, & Parekh, 2010;
Burghen, 2005; Fifield et al., 2010; Graham, 2014; Jacobson & Gance-Cleveland, 2011;
Karve & Hayward, 2010; Wiley et al., 2015; Xiang, Wethington, Onufrak, & Belay,
2014). This limited research, with 50% focusing on pediatrics, has left a gap in
understanding how integrative patient centered training may positively impact MetS
symptoms in adults. The most influential factor for reducing cardiovascular and diabetic
symptoms, which may be promoted by positive patient engagement, is ideal lifestyle and
behavioral changes (Jacob & Serrano-Gil, 2010; Kones, 2013; Nield, 2008; Wolever et
al., 2011). In addition to the gap in research, the concept of patient engagement has been
poorly defined and has been interpreted and applied in nonstandardized ways by
stakeholders across the health care industry. This is contributing to confusion regarding
this complex concept that has the potential for effective application including improving
self-health promotion, medication adherence, and health outcomes (Barello, Graffigna, &
Vegni, 2012; Bertakis & Azari, 2011; Institute of Medicine, 2001).
Gaps in understanding patient engagement indicate the need for ongoing research
to further define and understand the various applications and impact of patient
engagement on medication adherence and health outcomes (Barello et al., 2012; Bertakis
& Azari, 2011; DiMatteo, Hays, & Sherbourne, 1992; Dunbar-Jacob & MortimerStephens, 2001; Institute of Medicine, 2001). Much qualitative and quantitative research
has been done around patient engagement; however, there is little consensus on what this
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concept means, and limited understanding of how it is used throughout the medical
industry. Patient engagement is defined by the Agency for Healthcare Quality and
Research (AHQR, 2011) as “an ongoing process in which patients take an active role in
their own healthcare” and involves how factors such as “personal skills, motivation, and
behaviors - affect an individual’s ability to effectively engage in care” (p. 1). Barello et
al. (2012) described the confusion around the widely used term and recommended a
multi-perspective approach such that various aspects are analyzed to include “interaction
between its individual (i.e., emotional, cognitive and behavioral, etc.), relational (i.e.,
patient health providers, patient caregiver,...etc.), and organizational (i.e., type of health
care settings,…role and attitude of health professionals, etc.), dimensions across the
specificities of each single disease” (p. 7). Barello et al. determined that additional
research is required to develop empirical evidence based on theoretical construct taking
into account what factors affect patient engagement. Based on the lack of conformity
around the meaning and use of the term patient engagement, research conducted to
methodically define, develop, and establish practical and economically feasible
application is necessary. This study addressed the effects of an integrative patient
centered provider training protocol on integrative patient centered and whether there was
an associated effect on medication adherence and health outcomes. Two groups of
patients were compared: (a) providers trained on integrative patient centered care (the
intervention group), and (b) providers not trained on integrative patient centered care (the
control group).
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Background
Patient engagement is defined by the Agency for Healthcare Quality and Research
(AHQR, 2011) as “an ongoing process in which patients take an active role in their own
healthcare” and involves how factors such as “personal skills, motivation, and behaviorsaffect an individual’s ability to effectively engage in care” (para 1). Simmons, Wolever,
Bechard, and Snyderman (2014) followed this definition with their systematic review of
clinical trials on patient engagement. Out of 543 abstracts evaluated, only 10 trials met
the researchers’ criteria that defined patient engagement as (a) understanding the
importance of taking an active role in one’s health and health care; (b) having the
knowledge, skills, and confidence to manage health; and c) using knowledge, skills and
confidence to perform health-promoting behaviors (Simmons et al., 2014, p. 3).
Understanding what patient engagement is based on these criteria from the Agency for
Healthcare Research Quality and a large systematic review provided a foundation for
examining whether patient engagement was correlated with medication adherence and
health outcomes.
Problem Statement
Understanding how to use patient engagement to promote positive lifestyle
behaviors is key to improving health outcomes for MetS patients. Training health care
providers on the conceptual and practical application of integrative patient centered
engagement tools has not been studied as a method for patient engagement promotion. If
this component of health care and delivery was better understood and was shown to
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correlate with improved patient engagement, it may encourage providers to empower
their patients to practice motivated self-health care and medication adherence.
Purpose of Study
The purpose of this study was to assess how patient engagement in their health
care influenced health outcomes (MetS symptom improvement based on associated
biometrics) and medication adherence, defined as taking or not taking medication (noted
on electronic health record (EHR) or patient reported). Results may be used to develop
and implement practical and financially feasible practices that may promote improved
health care outcomes, increased medicine adherence, and enriched patient provider
engagement (Cox, 2011; Engel, 1977; Guarneri & Tager,, 2014; Simmons et al., 2014;
Williams, Frankel, Campbell, & Deci, 2000).
Nature of Study
I used a quantitative quasi-experimental design with a time interval method
employing a pre-intervention data capture (baseline) and post-intervention data capture at
approximately four months post-intervention training. I performed repeated measures
multivariate analysis of variance (MANOVA) (Campbell & Stanley, 1963; Creswell,
2009; Frankfort-Nachmias & Nachmias, 2008). The influence of patient engagement
factors on disease management outcomes biometrics (blood pressure, triglycerides, BMI,
blood glucose: serum and A1c, and high density lipoproteins) and medication adherence
(defined as taking or not taking) were compared between two patient groups within a
health care clinical system. The intervention group received integrative patient centered
care training, and the control group did not receive integrative patient centered care
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training. The intent of the intervention group was to determine the effects of newly
administered patient centered provider training on patients with MetS. I analyzed and
compared the differences between groups. The outcomes of the integrative patient
centered training can be compared to other patient engagement efforts to determine levels
of effectiveness based on disease management outcomes and medication adherence.
A patient engagement research predictor/independent variable (provider
integrative patient centered care education) was analyzed to determine its influence on
dependent variables (subsequent health outcomes and medication adherence).
Research Questions (RQs) and Hypotheses
RQ1: Is there a difference in disease biometrics outcomes (blood pressure,
triglycerides, BMI, blood glucose: serum glucose and A1c, and high density lipoproteins)
in patients with MetS following implementation of a patient engagement provider
training protocol in an integrative health clinic?
H1n: There is no difference in disease biometrics outcomes (blood pressure,
triglycerides, BMI, blood glucose: serum glucose and A1c, and high density lipoproteins)
in patients with MetS following implementation of patient engagement provider training
protocol in an integrative health clinic.
H1a: There is a difference in disease biometrics outcomes (blood pressure,
triglycerides, BMI, blood glucose: serum glucose and A1c, and high density lipoproteins)
in patients with MetS following implementation of a patient engagement provider
training protocol in an integrative health clinic.
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RQ2: Is there a difference in medication adherence (EHR noted or patient
reported at clinical visit) in patients with MetS following implementation of a patient
engagement provider training protocol in an integrative health clinic?
H2n: There is no difference in medication adherence (EHR noted or patient
reported at clinical visit) in patients with MetS following implementation of a patient
engagement provider training protocol in an integrative health clinic.
H2a: There is a difference in medication adherence (EHR noted or patient
reported at clinical visit) in patients with MetS following implementation of a patient
engagement provider training protocol in an integrative health clinic.
Health outcomes and medication adherence were the dependent variables, and
integrative patient centered engagement provider training was the independent variable.
Conceptual Framework
The biopsychosocial construct is based on mind/body medicine in which a
person’s intrinsic capacities for disease prevention and healing are supported through
integrating the understanding of their biology, psychology, and social influences into
diagnosis and treatment; the biopsychosocial construct is often aligned with the patient
centered approach to health care and delivery (Bausell & Berman, 2002; Cox, 2011;
Engel, 1977; Fremont & Bird, 1999; Freudenreich, Kontos, & Querques, 2010; Klinkman
& van Weel, 2011; Levin, 2009; Mauksch, 2005; Montori, Brito, & Murad, 2013; Moss,
2003; Scherger, 2005; von Bertalanffy, 1950; Williams et al., 2000). “Biopsychosocial
care is complex work. It requires an attitude of caring for the whole person in all
dimensions, including the family, cultural, and social contexts” (Scherger, 2005, p. 445).
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Biopsychosocial care involves the provider listening to and engaging with the patient’s
explanation of his or her illness and issues, and aligning that insight with discussion and
treatment. This intentional provider-patient engagement takes into account the patient’s
biology, psychology, and social influences that can impact symptoms and disease
(Freudenreich et al., 2010; Gorgens, 2006; Montori et al., 2013).
Systems theory was founded by von Bertalanffy (1950) and was developed into a
more current version by Engel (1977), who discussed the biopsychosocial concept as the
impossibility of understanding illness without understanding the internal and external
environment from which the patient resides. This model is different from the
conventional biomedical model of care in which disease is observed according to the
biological symptoms that define it, and treatment of symptoms occurs through
pharmaceuticals and surgery (Bausell & Berman, 2002; Engel, 1977; Fremont, & Bird,
1999; Freudenreich et al., 2010; Gorgens, 2006; Levin, 2009). The biomedical model also
stems from two reductionist concepts: it reduces a complex disease process down to a
single factor, and mind-body dualism dictates separation of mental or behavioral issues
from biological or somatic issues (Engel, 1977; Freudenreich et al., 2010; Gorgens,
2006).
My research approach was inclusive, involving both a biopsychosocial and
biomedical understanding of the individual. The biomedical model was already in use
and was the common ground from which to apply the integrative patient centered care
training protocol. The integrative patient centered care training protocol comprised
biopsychosocial training modules that provided education and skill development for the
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health care provider with the intention of facilitating patient engagement to inspire or
motivate the patient to improve self-care behaviors and medication adherence.
Operational Definitions
Biopsychosocial: Taking into account the patient’s biology, psychology, and
social influences that can impact symptoms and disease (Freudenreich et al., 2010;
Gorgens, 2006; Montori et al., 2013).
Clinical inertia: “Lack of treatment intensification in a patient not at evidencebased goals for care. Clinical inertia is a major factor that contributes to inadequate
chronic disease care in patients with diabetes mellitus, hypertension, dyslipidemias,
depression, coronary heart disease, and other conditions” (O’Connor, Sperl-Hillen,
Johnson, Rush, & Biltz, 2005, p. 1).
Healthy behaviors: Include healthy nutrition, exercise, stress management,
restorative sleep, and pursuit of happiness (Guarneri et al., 2014).
Hemoglobin High A1c: ≤ 5.6 mg/dl.
High body mass index (BMI): ≤ 30 kg/m2 is correlated with increased MetS and
age (Beltrán-Sánchez, Harhay, Harhay, & McElligott, 2013).
High triglycerides: ≤150 mg/dl or treatment for this lipid abnormality
Hyperlipidemia: a metabolic condition causing high triglycerides and high
cholesterol.
Hyperglycemia: raised fasting glucose ≤ 100 mg/dl or diagnosed type 2 diabetes
(International Diabetes Federation, n.d.).
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Hypertension: ≤ 140 mm Hg systolic or diastolic ≤ 90 mm Hg or treatment
(Gionfriddo et al., 2014).
Low high density lipoproteins (HDL): > 40 mg/dl in men and > 50 mg/dl in
women or treatment.
Metabolic syndrome: “A cluster of conditions—increased blood pressure, a high
blood sugar level, excess body fat around the waist and abnormal cholesterol levels—that
occur together, increasing your risk of heart disease, stroke, and diabetes” (Mayo Clinic,
2014, para 1). These symptoms align with established biometric standards from the
International Diabetes Federation and American Medical Association JNC8 (International
Diabetes Federation, n.d.; Gionfriddo et al., 2014).
Patient centered: An approach putting patients at the center of care, engaging
their feedback, including them in decision-making, and ensuring they understand and are
aligned with the treatment and care (Bertakis, Klea, 2011; Ganesh, 2009; Kraetschmer,
Sharpe, Urowitz, & Deber, 2004; Tilburt et al., 2014).
Patient engagement: A patient being actively engaged in his or her health care
and having the knowledge and ability to perform health-promoting behaviors to manage
health (AHRQ, 2011; Simmons et al., 2014).
Assumptions, Limitations, and Delimitations
Assumptions
I assumed that NOVA Medical Group health care providers would participate in
training and apply new knowledge and skills to their MetS patient groups. Also, I
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assumed that all patient data were uniformly collected and results were compared using
industry-standard objective metrics.
Limitations
Limitations may influence outcomes due to the following: (a) nonrandomization
of sampling frame, (b) patients having only MetS versus a more advanced chronic
disease, (c) patients not returning for follow-up appointments within 4 months or seeing a
provider from a different group, and (d) providers not applying integrative patient
centered care training methods. A factorial purposeful sampling method was performed
with MetS patients as defined above. Patient data were not randomly allotted to a control
or research group but purposefully selected within the sampling frame. Because of the
group development and intentional placement of patient data into one of two groups due
to sampling frame constraints, randomized placement was not feasible.
MetS patients were filtered out and selected based on the biometrics discussed
above and/or their diagnosis of MetS. However, because only the above MetS symptoms
were assessed, there may have been other symptoms or diagnoses related to chronic
disease such as stroke or cancer that may not have been integrated into the assessment
because they were not realized at time of selection. This could have influenced the health
outcomes and the patient’s ability to engage in lifestyle changes and medication
adherence.
A third potential limitation was whether those selected for this study returned for
follow-up appointments or whether they saw a different provider. In both groups, there
was the potential that patients who had initial data collected on them did not return for
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follow-up appointments with the originally assigned provider, at which time more
biometric data would have been collected. Because I de-identified all patients and was
only assessing de-identified data, no patient consent was requested, and neither
information nor incentives were given to motivate patient cooperation in this study. This
may have reduced the amount of patient biometric data collected post provider training,
thus potentially skewing results. In addition, there was the possibility that all biometrics
received initially may not have been captured the next time based on providers’ clinical
decisions and patient needs. If a lab biometric assessed initially was not indicated to be
performed by the provider at the follow-up appointment, providers were under no
obligation to have it performed and followed clinical practice guidelines. In addition,
patients were aligned with their primary provider and divided into one of two research
groups; it was possible they were not followed up by the original primary care provider
and were seen by a provider from a different group, in which case their data would have
been invalid.
Integrative patient centered care training was provided to one of two group of
providers; it offered ideas, methods, and approaches that were intended to advance the
provider’s ability to engage with patients to promote healthy lifestyle behaviors, known
as patient engagement. However, providers are different in how they learn and their
ability to apply this training to their clinical patient visits. Also, the patient may not have
had any desire to listen and apply suggestions on lifestyle and medication adherence
regardless of how competently the provider engaged with them. These limitations on
training, applicability, and patient acceptance, as well as the other limitations of non-
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randomization of the sampling frame, and the possibility of patients not returning for
follow-up appointments with their original provider, should be considered when
assessing the results of the study.
Delimitations
Delimitations that frame this study included (a) applying a quantitative versus
qualitative research methodology, (b) not conducting patient based surveys, (c) not
researching chronic conditions as opposed to metabolic syndrome only, and (d) excluding
those with conditions that may have impacted their biometrics or capacity to change
lifestyle behavior and/or adhere to treatments such as those with severe psychological
conditions.
Methodology. A quantitative methodology was chosen based on time frame
limitations, including not having the time necessary to receive patient consent and NOVA
Medical Group’s preference for my research study. Keeping the time frame of this study
to a practical 12 months warranted a quantitative rather than qualitative approach. There
was not enough time to set up observational studies to include patient consent and
integrating NOVA Medical Group’s provider-patient workflow into a qualitative study.
Using a quantitative method and collecting biometrics and medication adherence data at
timed intervals allowed for more efficient data collection. However, not having patient
based information on the provider’s engagement approach and how they feel overall is a
limitation in this study and should drive additional qualitative and quantitative studies. In
addition, not being able to observe the providers with their patients prevented the ability
to analyze and assess various themes of provider approach, training application, patient
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reactions, and engagement that could drive provider training protocol development and
be a factor in patient engagement.
Patient surveys. Understanding how patients feel about their providers, their
treatments, and their personal health goals is a component to understanding overall health
outcomes. Health outcome measurements for this study were limited to biometrics.
Measurements did not include how the patient feels, which may be a key indicator of
health and quality of life improvement. If patient engagement is based on behavior
modification and behaviors are affected by how someone feels, then this could be a
significant factor that should be pursued in future research.
Scope of patient population. Patient selection criteria were limited to those
diagnosed with or meeting the standards for MetS. This was done to target a population
that had the largest increased risk of developing a chronic condition, and intervening at a
point most critical for initiating self-health promoting behaviors (i.e., patient
engagement) to influence or reverse the potential disease trajectory. It was known that
this population was at higher risk for chronic disease than those without MetS condition.
Conditions impacting participation. Patients with other limiting conditions
identified through established research methods such as electronic health record diagnosis
were excluded. Limiting conditions may have significantly limited their ability to employ
healthy patient engagement behaviors that may have impacted and potentially skewed
biometric analysis outcomes (i.e., psychological impairments, disease diagnosis, physical
or learning impairments). Such psychological conditions would include those that dictate
24/7 patient care and advanced dementia (e.g., Alzheimer’s). Disease possibilities
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included cancer that was being actively treated and congestive heart failure. If a disease
was listed in the diagnosis section and there was a question of whether this might have
significantly affected health outcomes and medication adherence, then I consulted with
and receive guidance from lead medical providers, Dr. Grace Keenan or Dr. Chris
Connolly, of NOVA Medical Group.
Consent, Privacy, and Sampling Frame
Health care providers were given a research identification number so they could
be de-identified and correctly associated with their patient group (intervention or
control). Patient information and provider information was de-identified and assigned
into one of two research groups depending on location and quantity, and in accordance
with internal review board criteria. No personal or private health information was
associated with patients or providers in this study.
Given the sampling frame of four NOVA Medical Group clinics, the population
was selected from those with the following MetS criteria: hyperlipidemia (high
triglycerides and high cholesterol) and hypertension. The intent was to enroll 500
participants from the MetS population with approximately 50% in each group so that the
sample size would be determined around the parameters of 2.5% margin of error, 90%
confidence interval, and standard deviation of .5.
A repeated measures MANOVA was performed and included assessing and
comparing one independent variable with multiple dependent variables. Statistical
Package for the Social Sciences (SPSS) statistical program was used.
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Significance of the Study
It was essential to understand what health care providers can do to motivate their
patients to follow treatment plans and engage in their health behaviors. Learning and
applying provider-patient engagement tools and skills may be a significant factor in
improving patient health outcomes and medication adherence. Patient engagement and
healthy behaviors are proven to have the highest impact on improving health outcomes
and quality of life (Jacob & Serrano-Gil, 2010; Kones, 2013; Nield, 2008; Wolever et al.,
2011). These study outcomes are aligned with patient engagement behaviors that are
potentially influenced by the relationship with their provider. How a provider engages
with patients during the onsite patient appointment may prove to be a key factor in
improving patient health outcomes and medication adherence. It may improve patient
awareness, self-health promotion, and improved health. This may have a significant
positive impact on patients’ quality of life, how they perform their day-to-day activities,
and how they are able to meet their personal health goals (e.g., playing with grandkids,
running a 5K, working all day without pain, etc.). When patients are educated and
empowered to work with their health care providers and take ownership of their health,
then a positive ripple effect occurs producing beneficial changes within themselves, their
families, their employers/coworkers, their community, and beyond (Engel, 1977;
Williams et al., 2000).
This study was based on integrative patient centered provider training that may
support results to drive understanding and application of integrative patient engagement
methods and practices for those with Met S. The results may provide a platform for
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additional patient engagement research to develop a patient engagement protocol and its
potential applications. The study may provide processes and information for use in clinics
that are already patient centered (e.g., accountable care organizations and patient centered
medical homes). Additional benefits may include understanding what provider practices
influence patient behavior and what aspects of provider care are important to the patient,
all of which may have a direct impact on patients’ health-promoting behaviors and wellbeing.
There is a considerable amount of literature on MetS, patient engagement, and
provider education; however, there is limited research on all three in the same study
(Ampt et al., 2009; Brady et al., 2010; Burghen, 2005; Fifield et al., 2010; Graham, 2014;
Jacobson & Gance-Cleveland, 2011; Karve & Hayward, 2010; Wiley et al., 2015; Xiang
et al., 2014). This study may lead to improved patient medication adherence and
improved health outcomes, and become a basis from which to approach and treat MetS
and reinforce provider-patient engagement efforts. Knowing where to focus time, energy,
and finances is critical, especially to health care providers and researchers. Understanding
how to best support patient engagement and how to incorporate it into clinical practice
workflow via training and best practices around MetS may prove to be an industry-wide,
resource-saving, patient health promoting, and provider-friendly health care model
(Barello et al., 2012; Bertakis & Azari, 2011; Institute of Medicine, 2001; Rittenhouse,
Thom, & Schmittdiel, 2010; Simmons et al., 2014; U.S. Health Care Costs, 2012).
This study had a critical mission to assess the effects of patient centered
integrative provider education on MetS patients by identifying whether this training
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impacts patient engagement behaviors such that it influences medication adherence and
health outcomes.
Summary
Patient engagement includes behaviors that impact lifestyle choices such as
nutrition, exercise, stress management, restorative sleep, and pursuit of happiness. With
appropriate lifestyle behavior changes, MetS and chronic diseases throughout the U.S.
population may be significantly diminished. Primary care providers who develop patient
centered engagement skills through furthering their training may be better equipped to
influence patient engagement by using patient education and empowerment skills to
inspire patients to take charge of their health and medicine. Health care training that
provides conceptual and practical application of integrative patient centered care tools
may support individual patient engagement health behaviors that in turn may positively
impact MetS symptoms. This study has the potential to improve health outcomes, reduce
chronic disease, decrease health care spending, and improve the overall life of those
suffering with MetS.
In Chapter 2, I present a literature review to provide an in-depth understanding of
the theoretical foundation and biopsychosocial model used for this study. I describe
strategies for searching the literature, the theoretical framework, and definitions and
application of associated aspects of patient engagement, MetS, and medication
adherence. It offers a comprehensive understanding of the basis for provider integrative
patient centered care, training, and application. Patient engagement was searched and the
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results yielded gaps regarding consistent definitions of this term in the health care
industry, thereby prompting further development, defining, and use of this term.
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Chapter 2: Literature Review
In this quantitative quasi-experimental study, I examined potential relationships
between MetS patients’ health outcomes measured in biometrics (blood pressure,
triglycerides, BMI, fasting blood glucose, hemoglobin A1c, high density lipoproteins)
and medication adherence defined as taking or not taking (EHR noted or patient reported
at clinical visit) and providers trained in patient centered engagement practices. This
chapter includes literature search terms, the biopsychosocial theoretical framework,
limitations of the biopsychosocial model in a primary care setting, patient engagement,
MetS association with medication adherence, improved health outcomes, and provider
education.
Organization of the Review
Significant studies were examined and integrated into the literature review. The
first section presents strategies for searching the literature including search terms around
the concepts of biopsychosocial, patient engagement, MetS, and provider education. The
next section addresses the biopsychosocial theoretical framework, its evolution from
general systems theory to the biopsychosocial construct in patient diagnosis and
treatment, and its current application in this study. Views on the limitations of the
biopsychosocial model with regards to its lack of comprehensiveness and the practical
implications of limited time for use in daily clinical practice are given. Section three
provides a definition and criteria for patient engagement in this study. Next an overview
on MetS is presented, describing the link between MetS and chronic disease, the high
population affected by both, and the lack of research on how provider training may
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impact patient engagement and improve health outcomes. Lastly, health outcomes and its
correlation with medication adherence are discussed along with integrating provider
training to improve both of these factors. The chapter concludes with a summary.
Strategies for Searching the Literature
I used Google Scholar, ProQuest, Sage, PubMed, Thoreau: Multiple Databases,
Cochrane database, and books. The literature search focused around four main areas: (a)
patient engagement and treatment, (b) MetS, (c) provider education (2009-2015), and (d)
biopsychosocial models. Boolean operators were used to refine the search. Key search
terms for patient engagement and treatment included patient engagement, personalized
care, physician patient engagement, provider engagement, congruence, shared decision
making, adherence, compliance, patient provider symmetry, participatory medicine,
relationship centered care, patient empowerment, patient centered, collaboration,
engagement, and self-management. Key search terms for metabolic syndrome included
metabolic syndrome, chronic disease, metabolic syndrome symptoms, hyperlipidemia,
hyperglycemic, pre-diabetes, body mass index, cholesterol, and obesity. Key search terms
for provider education were filtered first by date range 2009-2015 to ensure most recent
training protocols and research, and included the following: provider training, provider
education, doctor education, doctor training, and provider behavior; all terms were
searched with chronic disease and metabolic syndrome. The key search terms for
researching biopsychosocial theory and constructs were biopsychosocial, mind/body
medicine, mind/body/spirit medicine, mind/body treatment, mind/body/spirit treatment,
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comprehensive treatment, and patient centered. All terms were searched with chronic
disease and metabolic syndrome.
Theoretical Framework
I used the biopsychosocial construct based on mind/body medicine in which the
intrinsic capacities for disease prevention and healing are supported through integrating
understanding of biology, psychology, and social influences into diagnosis and treatment
(Bausell & Berman, 2002; Cox, 2011; Engel, 1977; Fremont & Bird, 1999; Freudenreich
et al., 2010; Levin, 2009; Montori et al., 2013; Moss, c2003; von Bertalanffy, 1950;
Williams et al., 2000). In his outline of general systems theory, von Bertalannffy (1950)
described how within a living organism or any system, the whole is made up of
interacting components that result in organized complexity, and that independent parts of
the organism cannot be studied independently to understand the whole. This seminal
work in systems theory laid the foundation for understanding and applying the
biopsychosocial model in health care, diagnosis, and treatment.
Biopsychosocial Model
Engel (1977) described the impossibility of understanding illness without
understanding the internal and external environment of the patient. This involved the
provider engaging with patients to comprehensively assess the multiple facets that affect
health. The approach included provider-patient centered engagement skills that take into
account the patient’s biology, psychology, and social influences that can impact
symptoms and disease (Engel, 1977; Freudenreich et al., 2010; Gorgens, 2006; Montori
et al., 2013). The integrative patient centered training protocol was comprised of
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biopsychosocial training elements that provide education and support skill development
with the intention of facilitating patient engagement behaviors to inspire or motivate the
patient to improve self-care behaviors such that they positively influence medication
adherence and health outcomes.
Cox (2011) built on Engel’s biopsychosocial model and included the
body/mind/spirit paradigm that supports the “emerging desire for greater multiprofessional collaboration…an integrative focus for those who recognized the conceptual
limitations of a medical practice based on biomedicine alone” (p. 352). Cox also
suggested integrating relationship-based medicine or patient centered care, “which
incorporates meaning and purpose (spirit) as well as science and psychology” (p. 352).
This contributed to the current understanding and application of the biopsychosocial
model in which a provider assesses a patient’s biology, psychology, and sociocultural
aspects to more comprehensively and effectively diagnosis and treat, which aligns with a
patient centered approach to health care and delivery.
Biopsychosocial Model Limitations
Limitations noted here do not diminish the biopsychosocial model’s established
efficacy in primary care and treatment, but they do address concerns in its comprehensive
and effective application. First is the issue of not including basic elements into the patient
centered inquiry, like ruling out neuropsychological conditions, becoming more precise
in learning the patient’s biggest concerns, and realizing that what the patients want and
why may be very different from what the provider understands and practices. Second, the
application of the biopsychosocial model in a clinical setting using the patient centered
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approach takes time. It takes knowledge of information technology and electronic health
record systems, knowledge of the classification codes to appropriately link counseling
and treatment to codes that align with the biopsychosocial model and reimbursement, and
knowledge of creative processes to integrate all of these components into practical
workflows in a patient centered care setting. This requires time to train and most
importantly time to work in a clinical setting with patients who usually have more than
one health care issue to assess. This is not only a huge challenge in a fee-for-service
model in which time is limited and the number of patients seen is maximized, but in most
health care and delivery models in which time is often a factor and function of
reimbursement and revenue.
Adding to the biopsychosocial model. Freudenreich et al. (2010) discussed the
application of the biopsychosocial model in clinical settings and its shortcomings and
potential improved guidelines. Freudenreich et al., identified three guidelines for
clinicians to use when inquiring: “1) Think neuroanatomically; 2) Think existentially;
and 3) Think “dirty;” that is, understand that patients and physicians sometimes work
toward different goals” (p. 365). This approach still includes the biopsychosocial model;
however, providers are using portions of it more judiciously and adding components that
had been overlooked by many who employed it (Freudenreich et al., 2010). The
biopsycho portion points toward thinking neuroanatomically and finding out whether
there is any common neurological condition present if cognitive, behavioral, or affective
symptoms are noted. Basically providers want to rule out any biopsycho issue that could
impact clinical diagnosis, treatment, patient decision-making, and self-care. However,
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with this approach comes the added requirement for physicians to understand what to ask,
how to interpret, and how to apply information received into diagnosis and treatment in a
timely fashion. It is essential that training, workflow processes, proper coding, and time
with patients integrate these additional components.
Thinking existentially is recommended to ask questions that get to the core of
what may be bothering the patient without all of the other social questions potentially
asked on a patient centered intake. Freudenreich et al. (2010) suggested asking what the
patient’s biggest fear is based on current life circumstances and that every physician
should be able to help patients through “times of loss, fear and uncertainty” (p. 367).
Even with this approach it is important not to get engulfed in the patient’s problems and
suffering but to know enough to support the underlying needs and take time to ask
questions, listen, and employ the most aligned and beneficial response and treatment.
The final aspect covered by Freudenreich et al. (2010) is described as “think
dirty,” the idea that patients may sometimes have ulterior motives for wanting certain
treatments or care, not to suggest that patients are bad but to merely to state that a
physician must be aware of possibilities not necessarily related to the physician’s
presumed reasons for the medical appointment (p. 368). Freudenreich et al. noted that a
doctor should not try to be everything to his or her patients and that the patient’s wants
may not align ethically and/or along the lines of how a provider plans to treat; this
ensures a provider’s training, skills, expertise and ethics are not overridden by a patient’s
demands, regardless of potential patient backlash.
Not enough time with patients. One of the biggest challenges for health care
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providers is not having enough time with patients to adequately perform a comprehensive
intake, listen to patients, and provide the counseling and care necessary, especially in a
patient centered care setting (Klinkman & van Weel, 2011; Mauksch, 2005; Scherger,
2005; Tilburt et al., 2014). The biopsychosocial model is complex and aligned with
patient centered care in which providers take into account the whole patient including
family, culture, social aspects, psychology, and biology (Freudenreich et al., 2010,
Klinkman & van Weel, 2011; Mauksch, 2005; Scherger, 2005). Having enough time to
apply and practice the biopsychosocial model of care presents challenges in
understanding the model, incorporating the practice into clinical workflow, and being
reimbursed for these patient centered practices.
Patient Engagement Factors
Patient engagement is described as self-health promoting behaviors that influence
health outcomes. This health behavior dynamic was the basis for the study. Determining
what factors impact patient engagement is important. Research was conducted to
determine whether provider patient centered training was a factor in patient engagement,
and whether it is necessary to understand one of many potential factors that may impact
why and how a patient engages in his or her health care. In the health care industry, there
is limited consensus around the term patient engagement, so this literature search was
performed to determine the best definition supported by research and aligned with the
constructs of this study (Barello et al., 2012; Bertakis & Azari, 2011; DiMatteo et al.,
1992; Dunbar-Jacob & Mortimer-Stephens, 2001; Institute of Medicine, 2001). In
addition, I searched metabolic syndrome to determine associated symptoms and
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biometric values in order to have established standards to ensure reliable metrics and
analytical comparisons. Provider education, this study’s independent variable, was
searched to have a fuller understanding of the potentially positive impact on patient
engagement and health outcomes.
Patient Engagement Defined
I used two areas of literature for my patient engagement definition in this study.
First, patient engagement is defined by the Agency for Healthcare Quality and Research
(AHQR, 2011) as “an ongoing process in which patients take an active role in their own
healthcare” and involve factors including “personal skills, motivation, and behaviorsaffect an individual’s ability to effectively engage in care” (p. 1). Second, Simmons et al.
(2014) used this definition in their systematic review of clinical trials on patient
engagement. Simmons et al. evaluated 543 abstracts, and only 10 trials met their criteria
that defined patient engagement as (a) understanding the importance of taking an active
role in one’s health and health care; (b) having the knowledge, skills, and confidence to
manage health; and (c) using knowledge, skills, and confidence to perform healthpromoting behaviors.
Patient Engagement Improvement and Improved Health Outcomes
Out of the 10 trials mentioned above, four were used to measure knowledge,
confidence, and skills of patient engagement (Hibbard, Mahoney, Stock, & Tusler, 2007;
Lorig et al., 2010; Lorig, Ritter, Villa, & Armas, 2009; Wolever et al., 2010). Five (50%)
used chronic disease metrics like the ones used in this study (Barlow, Edwards, & Turner,
2009; Glasgow et al., 2012; Goeppinger, Armstrong, Schwartz, Ensley, Brady, 2007;
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Huang, Li, & Wang, 2009; Lavery, O’Neill, Parker, Elborn, & Bradley, 2011). One trial
used a self-efficacy measure (Moriyama et al., 2009). In addition these studies had
behavioral measures, with one measure being medication adherence, which aligns with a
measure that was assessed in this study (Glasgow et al., 2012). Nine out 10 (90%)
reported improved patient engagement (Glasgow et al., 2012; Goeppinger, Armstrong,
Schwartz, Ensley, Brady, 2007; Hibbard et al., 2007; Huang et al., 2009; Lavery, O’Neill,
Parker, Elborn, & Bradley, 2011; Lorig et al., 2010; Lorig, Ritter, Villa, & Armas, 2009;
Moriyama et al., 2009; Wolever et al., 2010).
Aligned with patient engagement improvement there were five studies or 50%
that showed clinical biological outcome improvements (Glasgow et al., 2012; Lorig et al.,
2010; Lorig et al., 2009; Moriyama et al., 2009; Wolever et al., 2010). Specifically
HbA1c, lipids, blood pressure were the same biological indicators this study assessed.
This research, which examined 543 abstracts on patient engagement, narrowed them
down to 10 trials that had three components that were used to frame and support their
research (a) understanding the importance of taking an active role in one’s health and
health care; (b) having the knowledge, skills, and confidence to manage health; and (c)
using knowledge, skills and confidence to perform health-promoting behaviors (Simmons
et al., 2014, p. 3). The study supported the correlation between patient engagement and
improved health outcomes and stated, “the role of patient engagement in chronic disease
care is increasingly being cited as critical for improving health outcomes and reducing
costs” (Simmons et al., 2014, p. 12). These 10 trials had the above three components
which drove the criteria and standardization of components that defined this research
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protocol. In addition it was the foundational study for directing further research that
reported the link between patient engagement and improved health outcomes. The term
patient engagement for this research was established based on Simmons et al. (2014)
three criteria that also aligned with AHRQ’s standard definition. This provided a reliable
and valid foundation for use, application and development of this patient engagement
concept.
Metabolic Syndrome Delineated
Metabolic syndrome describes a person with three or more symptoms or
precursors to chronic diseases ( cardiovascular disease, type 2 diabetes, and stroke) (Crist
et al., 2012; Dickerson et al., 2011; International Diabetes Federation, n.d.; Ma & Zhu,
2013). The symptoms include, high body mass index, high waist circumference,
hyperglycemia, low cholesterol high-density lipoprotein (HDL), and high triglycerides
(Crist et al., 2012; Burghen, 2005; International Diabetes Federation, n.d.; Ma & Zhu,
2013). Diminishing the rate of MetS can reduce chronic disease such as cardiovascular
and diabetes type II which costs the U.S. over 75% of our nation’s 2 trillion spent on
healthcare (CDC, 2011).
Association Between MetS and Chronic Disease
The association between MetS and chronic disease has been established by
multiple studies. A 2010 study analyzed GE Centricity electronic medical record (EMR)
data that captured patient level clinical data from clinical data services (CDS) that used
over 133 provider groups containing 7259 physicians at 98 installations and 8.9 million
de-identified patient standardized data (Crawford et al., 2010). The study assessed
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potential relationships between “obesity and 3 key chronic disease states: type II diabetes,
hyperlipidemia, and hypertension. The positive association between obesity and the 3
comorbid conditions in the GE Centricity database is similar to that found for US
populations” (Crawford et al., 2010, p.157). A more recent study indicated a significant
relationship between symptomatic carotid disease and metabolic syndrome,
demonstrating MetS indicators such as high triglycerides, obesity, and high glucose
levels are associated with cardiovascular disease (Maksimovic, Vlajinac, Radak,
Marinkovic, & Jorga, 2012).
According to the National Health and Nutrition Examination Survey (NHANES)
statistics 2002-2006 report, approximately 34% of adults over 20 years old meet the
criteria for metabolic syndrome and that MetS increased with age and body mass index
(Ervin, 2009). The 40-59 years old of males and females showed a three times higher
incidence of meeting MetS criteria than 20-39 year olds. Males over 60 years were four
times more likely and females over 60 years were six times more likely over the younger
group to meet MetS criteria (Ervin, 2009). A more recent study used the NHANES 1999
to 2010 surveys in two year waves; these indicated that within the U.S. population
approximately one-fifth of adults had a cardiometabolic risk (Beltrán-Sánchez et al.,
2013). These statistics indicated 34% of adults in the U.S. have metabolic syndrome and
one fifth of these adults specifically had cardiometabolic risk (Beltrán-Sánchez et al.,
2013; Ervin, 2009). These large study statistics indicated a clear and present need to
understand how to diminish MetS to prevent the onset of chronic disease, mortality,
morbidity and extreme health care costs.
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Diet and Exercise Behaviors Influence MetS
As discussed there was an abundance of research on metabolic syndrome,
however gaps were found in best practices and ways to prevent these symptoms (Appel,
Jones, & Kennedy-Malone, 2004; Burghen, 2005; Dickerson et al., 2011; Ma & Zhu,
2013). A Cochrane study reviewed the effects of exercise and diet, or exercise only on
people at high risk for type 2 diabetes, an indicator of MetS. The study included eight
trials with 2,241 participants in the exercise plus diet group and 2,509 participants in the
standard recommendation group (Orozco, 2008). Orozco concluded that diet with
exercise had a significant effect on those in high risk groups described as those with
MetS or impaired glucose tolerance (Orozco, 2008). This meta-analysis was limited in
understanding the “effects of exercise and diet on quality of life, morbidity and mortality,
with special focus on cardiovascular outcomes” (Orozco, 2008, p.5). However the study
used biometric outcomes to measure MetS indicators, and the relationship of diet and
exercise behaviors on biometrics associated with MetS.
If providers know methods to motivate patient engagement then positive lifestyle
behaviors, (e.g., diet and exercise) may be facilitated. Some providers may not have
received training in how best to motivate patients and encourage positive life style
behaviors, however training is available now. Research depicts the link between provider
training and influence on patient behavior thereby health outcomes, so it is plausible
based on the literature that MetS patient engagement behaviors may be impacted by
provider training (Ampt et al., 2009; Brady, Solomon, Neu, Siberry, & Parekh, 2010;
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Burghen, 2005; Fifield et al., 2010; Graham, 2014; Jacobson & Gance-Cleveland, 2011;
Karve & Hayward, 2010; Wiley et al., 2015; Xiang, Wethington, Onufrak, & Belay,
2014).
Another aspect of MetS review was to determine what biometrics were the best
indicators of this condition and most commonly collected. These biometrics were: blood
pressure, triglycerides, BMI, fasting blood glucose, and/or high density lipoproteins
(Burghen, 2005; International Diabetes Federation, n.d.; Ma & Zhu, 2013).
Medication Adherence, Improved Health Outcomes, and Provider Education
Medication adherence and improved health outcomes. Medication adherence
is a major contributing factor in improving health outcomes. The World Health
Organization (WHO) stated those with chronic conditions have a 50% treatment nonadherence rate (World Health Organization, 2003). The consequences “include
worsening condition, increased comorbid disease, increased health care costs, and death”
(Chisholm-Burns & Spivey, 2012, p. 826). There are different reasons for medication
nonadherence however a shared approach of collaboration and communication between
healthcare providers and their patients with aims for a common goal of improved health
outcomes may be key (Brunton, 2011; Chisholm-Burns & Spivey, 2012; Khanna et al.,
2012; McHorney & Spain, 2011).
A 2014 study using 649,904 patients diagnosed (based on International
Classification of Disease 10 codes) with hypertension, 199,312 diagnosed with diabetes
and 290,543 diagnosed with hyperlipidemia indicated there were higher hospitalizations
with poor medication adherence from patients with hypertension, hyperlipidemia and
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diabetes (Han, Suh, Lee, & Jang, 2014). In addition to hospital related medicine
nonadherence costs, a study by Khanna, et al., (2012) stated 4 billion prescriptions in the
United States were dispensed contributing to 10% of the overall 2.5 trillion in health care
costs with approximately half of the medication not taken as prescribed. More important
than the financial health care costs are the deaths associated with poor adherence
estimated at 125,000 individuals per year, in addition to the adverse effects associated
with morbidity (Khanna et al., 2012; Makarem, Smith, Mudambi, & Hunt, 2014). The
financial, physical, and emotional ramifications of nonadherence is highlighted by the
statistic that half of those who fill a prescription do not continue the medicines after six
months (Brunton, 2011; McHorney & Spain, 2011). Medication adherence directly
correlates with health outcomes and is a significant challenge. Supporting this component
of patient care through provider education and improved patient engagement may
positively contribute to improved overall health outcomes.
Provider education. In my research provider education and training will be given
in order to promote health care providers’ ability to facilitate patient self-healthy
behaviors (patient engagement) such as better nutrition, exercise, stress management,
restorative sleep, pursuit of happiness and medication adherence (AHRQ, 2011; Brunton,
2011; Chisholm-Burns & Spivey, 2012; Cox, 2011; Engel, 1977; Guarneri & Tager,
2014; Khanna et al., 2012; Simmons et al., 2014; Williams et al., 2000). I will educate on
the understanding and application of biopsychosocial and patient centered care practices
that include family, culture and social aspects. This training will aim to promote patient
engagement around healthy behaviors and medication adherence.

34
Monitoring patient reported medication adherence is one way to determine if
patients are taking what is being prescribed. Improving medication adherence is a factor
in reducing morbidity and mortality (Brunton, 2011; Chisholm-Burns & Spivey, 2012;
Khanna et al., 2012; McHorney & Spain, 2011). Giving health care providers the tools
and training to improve patient engagement and thereby medication adherence is a key
factor in determining if training has an influence on patients taking prescriptions. Various
ways to improve medication adherence through patient provider relations and
communications on supporting health promoting behaviors have been researched (BoschCapblanch, 2009; Brunton, 2011; Makarem et al., 2014; Street Jr., 2013; Viswanathan et
al., 2012).
This research protocol includes provider patient engagement training and will
incorporate a cross-section of researched methods to include promoting cognitive and
emotional reasons (utilizing the biopsychosocial patient centered model) for taking
prescribed treatments, creating goals that are patient centered, and understanding and
integrating health literacy based on demographics and other patient intake information
(Bertakis, Klea, 2011; Bosch-Capblanch, 2009; Brunton, 2011; Makarem et al., 2014;
McHorney & Spain, 2011Street Jr., 2013; Rittenhouse et al.,, 2010; Viswanathan et al.,
2012; World Health Organization, 2003).
Literature searches revealed large amounts of research on MetS, patient
engagement, and provider education independently; however information is limited when
reviewed together or in different combinations (Ampt et al., 2009; Brady, Solomon, Neu,
Siberry, & Parekh, 2010; Burghen, 2005; Fifield et al., 2010; Graham, 2014; Jacobson &
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Gance-Cleveland, 2011; Karve & Hayward, 2010; Wiley et al., 2015; Xiang, Wethington,
Onufrak, & Belay, 2014). This gap in research on provider education and its potential
impact on patient engagement with metabolic syndrome patients drove my proposed
research study. Educational programs that advance provider patient engagement skills
and how to incorporate these into daily clinical practice may be a wise fiscal and
fundamental initiative (Barello et al., 2012; Bertakis & Azari, 2011; Institute of
Medicine, 2001; Rittenhouse et al., 2010; Simmons et al., 2014; Kaiser, 2012).
Summary
This literature review listed all significant search terms, the biopsychosocial
theoretical framework, and defined patient engagement. Patient engagement factors
described included metabolic syndrome, link between MetS and chronic disease, and the
large U.S. population affected. I highlighted the lack of research on provider training and
the potential impact this could have on patient engagement and medication adherence.
Major studies were examined to understand the immense amount of research performed
on patient engagement, in addition to the deficiency of research around my proposed
study of provider training to improve patient engagement behaviors. The following
chapter is an explanation of research methods used to analyze the effects of provider
education on patient engagement behaviors and therefore health outcomes and
medication adherence.
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Chapter 3: Research Methods
In this quasi-experimental study, I examined the potential effects of the
independent variable, integrative patient centered provider training, on the dependent
variables of health outcomes (biometrics) and medication adherence (EHR noted and
physician reviewed at clinical visit) of patients with metabolic syndrome. There is little
research addressing the correlation between provider training, patient engagement, and
health outcomes. Due to this gap, there was a need for further study. Follow-on studies
may enhance generalizability of findings.
This chapter presents the method and design and is organized into five sections.
The first section includes the reasoning for using a quantitative quasi-experimental design
and the research questions. The next section details the sampling and sampling
procedures, including the sampling frame and size. In the third section I identify the
dependent variables of health outcomes (disease biometrics) and medication adherence
(EHR noted) and the independent variable data (two provider groups). In the fourth
section, I describe the ethical considerations and how patient data was de-identified,
collected, and protected, as well as how ethical procedures were employed with the
provider groups to ensure understanding and agreement. The fifth section presents the
instrumentation and materials used. A summary concludes this chapter. The Institutional
Review Board (IRB) approval number for this research is 08-14-15-0330260.
Research Design and Approach
I employed a quantitative quasi-experimental design. The purpose was to
determine the potential effects of the independent variable (integrative patient centered
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provider training) on the dependent variables of health outcomes (biometrics) and
medication adherence (EHR noted) of patients with MetS. The metrics aligned with
established biometric standards from the International Diabetes Federation and American
Medical Association JNC8 (Gionfriddo et al., 2014; International Diabetes Federation,
n.d.). The biometrics included the following: (a) hyperlipidemia, metabolic condition
causing high triglycerides and high cholesterol; (b) high triglycerides, ≤150 mg/dl or
treatment for this lipid abnormality; (c) low high density lipoproteins (HDL), > 40 mg/dl
in men and > 50 mg/dl in women or treatment; (d) hyperglycemia, a raised fasting
glucose ≤100 mg/dl or diagnosed type 2 diabetes (International Diabetes Federation,
n.d.); (e) hypertension, ≤ 140 mm Hg systolic or diastolic ≤ 90 mm Hg or treatment
(Gionfriddo et al., 2014); and high body mass index (BMI) defined as ≤ 30 kg/m2 and
correlated with increased MetS and age (Beltrán-Sánchez et al., 2013).
I compared the efficacy of a patient engagement protocol on medication
adherence and health outcomes between two groups: (a) integrative patient centered
provider training for providers (intervention group), and (b) no integrative patient
centered training for providers (control group). The intent of the intervention groups was
to determine the effects of newly administered integrative patient centered provider
training on patients with MetS. This comparative effectiveness research analyzed and
compared the effects of integrative patient centered care training on medication
adherence and disease biometric outcomes of patients with MetS.
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Research Questions and Hypotheses
RQ1: Is there a difference in disease biometrics outcomes (blood pressure,
triglycerides, BMI, blood glucose: serum glucose and A1c, and high density lipoproteins)
in patients with MetS following implementation of a patient engagement provider
training protocol in an integrative health clinic?
H1n: There is no difference in disease biometrics outcomes (blood pressure,
triglycerides, BMI, blood glucose: serum glucose and A1c, and high density lipoproteins)
in patients with MetS following implementation of a patient engagement provider
training protocol in an integrative health clinic.
H1a: There is a difference in disease biometrics outcomes (blood pressure,
triglycerides, BMI, blood glucose: serum glucose and A1c, and high density lipoproteins)
in patients with MetS following implementation of a patient engagement provider
training protocol in an integrative health clinic.
RQ2: Is there a difference in medication adherence (EHR noted or patient
reported at clinical visit) in patients with MetS following implementation of a patient
engagement provider training protocol in an integrative health clinic?
H2n: There is no difference in medication adherence (EHR noted or patient
reported at clinical visit) in patients with MetS following implementation of a patient
engagement provider training protocol in an integrative health clinic.
H2a: There is a difference in medication adherence (EHR noted or patient
reported at clinical visit) in patients with MetS following implementation of a patient
engagement provider training protocol in an integrative health clinic.
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Health outcomes and medication adherence were the dependent variables, and
patient engagement patient centered provider training was the independent variable.
Sampling and Missing Data
Sampling Selection
I used a purposeful sampling protocol based on patients’ MetS data. The nature of
the sampling frame (such that limited number of patients met the study’s inclusion
criteria of having six MetS indicators) from NOVA Medical Group clinics, patient
randomization was infeasible however provider randomization was feasible. From eight
to 10 providers, four to five were used for Group 1 (integrative patient centered care
training), and four to five were used for Group 2 (integrative patient centered care
training). My sample was obtained through performing two series of patient data filtering.
The initial patient data filtering was based on those who had the following study MetS
indicators: hyperlipidemia (high triglycerides, high cholesterol) and hypertension. These
indicators were selected because they yielded the highest number of patients and
produced 515 patient data. A second filtering was performed on this initial set and used
the remaining research MetS indicators (HbA1c, fasting glucose, BMI) and produced 91
patient data, which was my applied research sample size. Because patient randomization
was not feasible, internal validity was strengthened by random division of providers who
had MetS patients; they were placed into two study groups (intervention or control) based
on creating comparable patient sample sizes for each provider group (FrankfortNachmias & Nachmias, 2008).
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Sampling Procedures
The patient data under study met the inclusion criteria of having the MetS
symptoms described above. Exclusion criteria included people less than 18 years of age
and those with conditions that may have impacted their ability to successfully employ
patient engagement behaviors (e.g., psychological or cognitive limiting conditions noted
on EHR). Patient information and data and provider information were de-identified and
assigned into one of two research groups depending on location and in accordance with
internal review board criteria.
The sampling frame was derived from four NOVA Medical Group clinics, and the
population was filtered by those having three of the six MetS indicators: hyperlipidemia
(high triglycerides and high cholesterol) and hypertension, and then on the remaining
three MetS indicators (HbA1c, fasting glucose, BMI) yielding 91 patient data.
Based on this sample size of 91 MetS patients the specified margin of error of
10.0% with a 80% power at 95% confidence level and a standard deviation of .5 with a
medium effect. With a confidence level at 95%, this corresponded to a z score of 1.96. To
find the sample size needed, I used the following formula. Necessary sample size = (Z
score)2 *StdDev* (1 StdDev) / (margin of error)2 = (1.96)2 x .5(.5) / (.10)2 = (3.84 x .25) /
.01 = .96 / .01 = 96.
With attrition estimated at 30%, the minimum required sample was (96 + 96*0.3 ~ =) 125
patients (Frankfort-Nachmias, Nachmias, 2008).
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Missing Data
Missing data could have occurred for multiple reasons. First, providers may have
opted out of the training at any point during the study. Another trained provider could
have taken over the patient cases if that provider met the group criteria (i.e., received or
had not received the intervention training). These potential scenarios should not have
affected the study sample size because sample size was based on patient numbers, not
number of providers. As long as the providers working with the assigned population had
or had not received the integrative patient centered care training, respectively, then all
other factors remained constant.
Another potential for missing data was having a provider from one research
group following-up with patients originally seen by the other group. Other challenges
included, patients that did not return for follow-up appointments within the four month
post intervention time frame, and research biometric labs not requested by the provider
and/or not performed by the patient.
Overall, 37 patients were assigned to provider Group 1 (intervention) and 54
patient to provider Group 2 (control). It was not possible to obtain data from additional
patients to meet the minimum required sample size of 125.
Assumptions
The assumptions for multivariate analysis of variance (MANOVA) were the
following:
1. Dependent variables are continuous variables measured at the
interval/scale level.
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2. The Independent variable clearly divides the study participants into two
independent groups (integrative patient centered care training, and one
group not given integrative patient centered care training).
3. Each study participant in a group was selected independent of other study
participant in the same group.
4. Each group has enough cases based on the minimum required sample size,
and the groups are balanced.
5. There are no extreme values (outliers) in the dependent variable and in
each of the covariates. In the current study, MetS biomedical parameters
had large variances due to their probable large deviations from normal
(non MetS) patients.
6. The dependent variable and each of the covariates measured on continuous
scale follow normal distribution.
7. There is linear relationships between dependent variable and each of the
continuous independent variables.
8. There is homogeneity of variance such that there are similar variances in
each of the groups. The assumption was assessed using Pillai’s criteria and
Box’s M test of equality of covariance. The assumption of homogeneity of
variance-covariance was not met, and the null hypotheses was rejected.
9. There should be no multicollinearity between continuous independent
variables (covariates) and they are not correlated with one another.
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Dependent and Independent Variables:
There are seven dependent variables in this study. The biomedical variables
include: blood pressure, triglycerides, body mass index (BMI), fasting blood glucose,
hemoglobin A1c, and high density lipoproteins. The medication adherence variable is
defined as “taking” or “not taking” medication (noted on EHR). The
independent/intervention variable is provider education on integrative patient centered
care, received or not received.
Dependent: Health Outcomes and Medication Adherence
The effects of patient engagement factors on medication adherence (EHR noted)
and disease management outcomes biometrics (e.g., blood pressure, triglycerides, body
mass index (BMI), blood glucose serum, HbA1c, and high density lipoproteins) were
compared between two patient groups within a health care clinical system.
Independent Variable: Provider Education
Two provider groups were established with respects to the independent variable.
The groups were comprised of providers who received integrative patient centered
training (intervention), and those providers who did not receive integrative patient
centered training (control). The intent of the intervention group was to determine the
effects of newly administered integrative patient centered provider training on patients
with MetS. This comparative effectiveness research analyzed and compared the potential
different effects from integrative patient centered training between provider groups. It
analyzed and compared the effects of integrative patient centered training on disease
management outcomes and medication adherence, and determined statistically significant
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relationships. These outcomes of integrative patient centered engagement training can be
compared to other patient engagement efforts to determine levels of effectiveness based
on medication adherence and disease management outcomes.
Provider training was developed based on patient centered health care methods
shown to improve patient satisfaction and health outcomes. These methods are based on
patient centered medical home (PCMH) tenets; accountable care organization criteria; the
health belief model; and current research integrating components of building healing
relationships, motivational interviewing, and the seek, help, assess, reach, evaluate
(SHARE) approach (AHRQ, 2012; Bertakis, Klea, 2011; Guarneri & Tager, 2014;
Institute of Medicine, 2001; Rittenhouse et al., 2010; Tilburt et al., 2014; Wolever et al.,
2011). There were approximately 65 health care providers in this study to include
medical doctors, nurse practitioners, doctors of naturopathic medicine, nutritionists, and
nurses; with anticipated 90% participation rate from the practitioners and nurses. The
training was a total of six hours divided up into approximately two hour blocks one day a
week for three consecutive weeks. I provided the training using audio-visual equipment,
PowerPoint presentations, participant role-play, humor, and team engagement. See
appendix A.
Data Analysis Plan
Repeated measures MANOVA was utilized to examine how each patient’s data
compared across the two capture periods. Baseline (pre intervention) patient data was
collected from the EHR at the start of active research (post IRB approval). This pre
intervention data capture was the last documented biometric and medication adherence
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data on patient EHR. Post intervention data (after provider training was given) was
collected after the patient’s follow-up clinical visit, approximately three to four months
after the last training class. Repeated measures MANOVA were performed and included
assessing and comparing one independent variable with multiple dependent variables.
SPSS statistical program was used for the analysis.
Research Questions
RQ1: Is there a difference in disease biometrics outcomes (blood pressure,
triglycerides, BMI, blood glucose: serum glucose and A1c, and high density lipoproteins)
in patients with MetS following implementation of a patient engagement provider
training protocol in an integrative health clinic?
Below is the example table for delineating the collected biometric data.
Table 1
Example Biometrics Data Collected
Variable

Provider Training Group
BMI Kg/m2
HbA1c %
Fasting Glucose mg/dl
Triglycerides mg/dl
Systolic BP mmHg
Diastolic BP mmHg
HDL mg/dl

Baseline Mean

Post Intervention Baseline Mean

± Standard Deviation

± Standard Deviation
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RQ2: Is there a difference in medication adherence (EHR noted or patient
reported at clinical visit) in patients with Metabolic Syndrome following implementation
of a patient engagement provider training protocol in a health clinic?
Below is the example table for delineating the collected medication adherence
data.
Table 2
Example Medication Adherence Data Collected
Variable

Pre Intervention (Baseline)

Post Intervention

Medication
Adherence:
reported at
clinical visit
and is
compliant or
noncompliant

Ethical Considerations
Patient data de-identified, collected and protected
Patients’ data were de-identified by removing all identifying information and
replaced with an identification research number. Only the primary investigator and
designated NOVA Medical Group (NMG) staff had access to this information. Because
initial patient de-identification was performed, no health and personal data was associated
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with the data, thus no HIPAA or privacy act violations were probable; therefore consent
from patients to use this data was not necessary (this determination was approved by the
IRB). The data were kept in password protected electronic files and all methods and
procedures around data complied with IRB, HIPAA, Privacy Act, and NMG regulating
criteria.
Provider Group Consent
All providers were divided into one of two groups. Those provided the training
were given a description of the research and their participator role. Provider
demographics were collected to include age, years of practice, degree, and medical
school attended, though these details were not integrated into study analysis. All
providers were de-identified and given a provider group number (1 or 2) and randomly
assigned to the intervention or control group.
Instrumentation and Materials
Biometrics scales and standards were based on industry standards as indicated
previously. SPSS software was used to establish analytical testing programs, produce
tables and drive interpretation of outcomes.
Summary
In summary this chapter discussed the details and development of my quantitative
quasi-experimental study. It showed what research methods and procedures were
employed to determine potential effects of the independent variable (integrative patient
centered training) on dependent variables (health outcomes) and medication adherence
(noted on EHR) of patients with MetS.
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Chapter 4: Results
This chapter presents findings of the integrative patient centered engagement
training study including patient data, demographics, descriptive statistics, data capture
challenges, data compilation, and data analysis. The previous three chapters introduced
and described the need for this study, provided an in-depth literature review, and research
methods were explained. In Chapter 4, I describe the use of repeated measures
MANOVA to test for significant differences between provider groups who had the
intervention (integrative patient centered training) and those who did not have the
training. In addition, I describe the analysis done across time to determine whether there
were significant differences between health outcomes. A summary of findings concludes
the chapter.
Research Data
Patient Data Numbers
Initial baseline patient data were collected within 12 months of intervention start
date (integrative patient centered training). Metabolic syndrome patient selection criteria
were based on a diagnosis of MetS and having baseline data on triglycerides, blood
glucose, HbA1c, HDL cholesterol, body mass index, blood pressure, and medication
adherence. After clinical chart review for complete post intervention data, the initial
sample size decreased from 91 total patient data, with 37 from Group 1 (provider training
intervention group) and 54 from Group 2 (control group who did not receive the
training), to 43 total patient data with 13 from Group 1 and 30 from Group 2. Due to the
diminished sample size an intention to treat (ITT) group was established utilizing
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baseline values cared forward. Analysis was performed on both the ITT group using the
original 91 patient data, and on the completer data set using 43 total patient data. These
two data sets will be described later in the chapter.
Patient Demographics
Age ranged from 31 years to 90 years, with the 46-60 range at 49.5% of
participants and 61-75 range at 37.4% of participants. Participants included 61.5%
females and 38.5% males. Demographic data are presented in Table 3 and Table 4.
Table 3
Age Range Data Set Comparing Provider Training Group (Intervention) and NonProvider Training Group (Control)

Provider ID

Intervention Provider
Training Group
Control Group NonProvider Training

Total (n)
Table 4
Female and Male Participants

Female
Male
Total

Number
56
35
91

Age Range of Patients Per
Total
Provider Group
31-45 46-60 61-75 76-90
Yrs
Yrs
Yrs
Yrs
3
19
13
2
37
2

26

21

5

54

5

45

34

7

91
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Descriptive Statistics and Sample Size
The total original sample was 91 with 37 patient data in the provider training
group and 54 patient data in the non-training group. Within this initial group of 91, data
were missing as indicated by lower numbers next to the biometric collected (see Table 5).
Data were analyzed using mean and standard deviation at two points in time, baseline and
post intervention measurement 3 to 4 months after intervention (provider training).
Descriptive statistics are presented in Table 5.
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Table 5
Descriptive Statistics for Research Population
Baseline
Mean ± SD Values

Provider Training Group:
Intervention
BMI Kg/m2 n = 37

32.92 ± 7.29

HbA1c % n = 36

5.98 ± .40

Fasting Glucose mg/dl n = 36

99.36 ± 11.81

Triglycerides mg/dl n = 35

146.03 ± 81.13

Systolic BP mmHg n = 37

127.43 ± 14.89

Diastolic BP mmHg n = 37

79.46 ± 12.77

HDL mg/dl n = 37

56.16 ± 18.28

Non-Provider Training Group:
Control
BMI Kg/m2 n = 54

31.51 ± 7.86

HbA1c % n = 48

5.99 ± .93

Fasting Glucose mg/dl n = 53

102.00 ± 37.96

Triglycerides mg/dl n = 48

148.40 ± 65.48

Systolic BP mmHg n = 53

132.26 ± 16.71

Diastolic BP mmHg n = 53

82.59 ± 12.85

HDL mg/dl n = 54

52.69 ± 16.53
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Data Compilation and Table
Research Question 1 was applied to both the completer data set (43 total patient
data) and the ITT data set (91 total patient data). The ITT data set used values carried
forward from baseline if the post intervention data was missing or had to be removed
because it invalidated the integrity of provider group. Research Question 2 could not be
answered due to discrepancy of outcomes; data did not achieve criterion validity
standards and construct validity was not met. The definition of medication adherence was
not consistently followed across patient EHRs, thus not reliable. If incorporated, results
would have been skewed and/or completely inaccurate. This finding is discussed in
Chapter 5.
Research Questions and Hypothesis
Research Question 1 assessed if there was a difference in disease biometrics
outcomes (blood pressure (systolic and diastolic), triglycerides, body mass index (BMI),
blood glucose (HbA1c and serum), and high density lipoproteins) in patients with
Metabolic syndrome following implementation of a patient engagement provider training
protocol in an integrative health clinic. The null and alternative hypotheses described if
there was or was not a difference in disease biometrics outcomes following implantation
of the patient engagement protocol.
Data Compilation and Completer Data Set
The completer data set had a total of 13 patient data from the provider training
group, and a total of 30 patient data from the nontraining group. It was noted that the
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small sample size could increase the likelihood of type II errors and a failure to reject a
false null hypothesis (Creswell, 2009; Frankfort-Nachmias & Nachmias, 2008). Mean
and standard deviation values were analyzed at two points in time, the baseline and at
three to four months post intervention. Within the completer data set, statistically
significantly (p < 0.05) values across time included a decrease in BMI within the provider
training Group 1 (from 35.14 ± 7.9 Kg/m2 to 33.65* ± 7.62 Kg/m2; p value for
difference < 0.05; Table 6); but not within the non-training Group 2 (32.4 ± 6.62 Kg/m2
to 32.4 ± 6.5 Kg/m2; p value for difference > 0.05; Table 6). There was an increase in
fasting glucose levels in both provider groups: training Group 1 (from 99.00 ± 12.84
mg/dl to 104.46* ± 20.12 mg/dl; p value for difference < 0.05; Table 6) and non-training
Group 2 (from 101.33 ± 13.40 mg/dl to 105.47* ± 18.60 mg/dl; p value for difference
< 0.05; Table 6). However, there was no statistically significant difference in BMI
between the training (intervention) and non-training (control) groups (p = 0.469).
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Table 6
Completer Data of Biometric Data Between Provider Groups
Baseline
Mean + SD Values

Post Measurement
Mean + SD Values

F Statistic

BMI Kg/m2

35.14 ± 7.87

33.65* ± 7.62

3.86

HbA1c %

6.07 ± .45

5.92 ± .34

2.88

Fasting Glucose mg/dl

99.00 ± 12.84

104.46 *± 20.12

4.28

Triglycerides mg/dl

164.15 ± 110.77

151.00 ± 84.54

.188

Systolic BP mmHg

129.46 ± 21.87

128.92 ± 21.18

1.816

Diastolic BP mmHg

81.08 ± 18.81

79.44 ± 18.71

.009

HDL Cholesterol mg/dl

51.54 ± 19.97

51.54 ± 18.93

.039

BMI Kg/m2

32.42 ± 6.96

32.13 ± 6.53

1.73

HbA1c %

5.91 ± .42

5.83 ± .45

.309

Fasting Glucose mg/dl

101.33 ± 13.40

105.47* ± 18.60

.082

Triglycerides mg/dl

150.70 ± 70.57

154.37 ± 66.30

.592

Systolic BP mmHg

136.80 ± 16.88

130.77 ± 15.60

1.27

Diastolic BP mmHg

81.42 ± 11.04

82.47 ± 11.90

.184

HDL mg/dl

53.70 ± 18.80

54.77 ± 20.14

.177

Provider Training Group
n=13

Non Training Group
n=30

Note. * Significant from baseline at p < 0.05
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Repeated measures MANOVA was performed with the completer data set.
Provider training group (intervention) and non-training (control) as the between subject
variables and time as the within subject variable, with two time points (pre and post
intervention).
Time has a statistically significant effect on fasting glucose level, such that fasting
glucose level significantly (F (1, 4) = 4.28, p < 0.05) increased over time. In addition, a
statistically significant (F (1, 4) = 3.86, p < 0.05) effect was found between follow-up
times and BMI for the training group (but not for the non-training group). Therefore, time
had a statistically significant effect on BMI in the training group alone, but as stated
previously there was no statistically significant difference between the provider training
groups. Because significance was only noted between time frames and not between
provider groups for both fasting glucose and BMI, the null hypothesis (there was no
difference in disease biometrics outcomes in patients with metabolic syndrome following
implementation of a integrative patient centered provider training protocol) was not
rejected. Also found, for the training group, the longer length of clinical care received by
patients (if all other conditions are kept constant) the lower patient’s BMI. This suggests
that training may have favorable effects on the outcomes, but not large enough to be
statistically significant.
Data Compilation and Intention to Treat
One method used to overcome data capture complications was to create the
intention-to-treat (ITT) data set. Baseline data were carried forward to fill in the missing
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or invalid data from both provider groups creating a whole data set with a total 91
patients. ITT data is a conservative estimate that is commonly used in clinical research
when attrition is noted (Gupta, 2011). When comparing the mean value, I examined
standard deviation and standard error pre and post intervention on the completer data set
(n = 43), and the ITT data set (n = 91). The difference in means between data sets of
provider groups (pre and post intervention) showed no significant variation between
groups and no similarities of either upward or downward trending values.
The ITT data set had a total of 37 patient data from the provider training group
and 54 total patient data from the nontraining group. ITT statistics are presented in Table
7.
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Table 7
Intent-to-Treat Analysis of Biometric Data Between Provider Groups with F Statistic
Baseline
Mean + SD Values

Post Measurement
Mean + SD Values

F Statistic

BMI Kg/m2

32.92 ± 7.29

31.64* ± 6.84

8.37

HbA1c %

5.98 ± .39

5.91 ± .38

2.85

Fasting Glucose mg/dl

99.59 ± 11.73

101.11 ± 16.37

.003

Triglycerides mg/dl

144.89 ± 79.16

143.16 ± 64.78

.002

Systolic BP mmHg

127.43 ± 14.89

129.62 ± 16.13

.292

Diastolic BP mmHg

79.46 ± 12.77

76.86 ± 14.1

.703

HDL Cholesterol mg/dl

56.16 ± 18.26

54.08 ± 18.09

.270

BMI Kg/m2

32.16 ± 6.65

31.49*±6.28

.810

HbA1c %

5.99 ± .88

5.94 ± .89

.019

Fasting Glucose mg/dl

105.76 ± 31.08

104.52 ± 17.93

.257

Triglycerides mg/dl

150.94 ± 66.31

152.19 ± - 61.94

.086

Systolic BP mmHg

131.48 ± 17.52

131.02 ± 15.84

.689

Diastolic BP mmHg

82.24 ± 12.98

81.55 ± 12.45

.235

HDL mg/dl

52.69 ± 16.53

53.48 ±17.74

1.355

Provider Training Group
n=37

Non Training Group
n=54

Note .* Significant from baseline at p < 0.05.
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Repeated measures MANOVA was performed with ITT group. Provider training
Group 1 (intervention) and non training Group 2 (control) as the between subject
variables and time as the within subject variable, with two time points (pre and post
intervention). Furthermore, the intervention (integrative patient centered training for
health care providers) has no statistically significant effect on BMI (Table 7) such that the
BMI for the patients whose health care providers received integrative patient centered
training and the BMI for the patients whose health care providers did not receive
integrative patient centered training did not differ to a statistically significant degree. In
addition, a statistically significant (p < 0.05) relationship was found between length of
clinical care for both provider groups and BMI such that (if all other conditions are kept
constant) the longer the length of clinical care received by a patient, the lower his/her
BMI.
Within the ITT data set statistically significant values across time included a
decrease in BMI in both the provider training group and nontraining group. However,
similar to the completer data set, there was no statistically significant difference in BMI
between the training and non-training groups in the ITT set (Table 7). While the
completer data set suggests possible (but not statistically significance) favorable effects
of the training, the ITT data set does not. Overall, I failed to reject the null hypothesis
(there was no difference in disease biometrics outcomes in patients with metabolic
syndrome following implementation of a integrative patient centered engagement
provider training protocol).
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The medication adherence research question 2 involved research measurement
criteria and outcomes data that ended up unreliable and invalid due to the pre intervention
definition and criteria of “not taking” on the electronic health record not being consistent
across patient EHRs. Due to this significant discrepancy within the medication adherence
measurement definition, RQ 2 was excluded. This finding is discussed in Chapter 5.
Conclusion
I conducted this study to determine whether integrative patient centered training
given to health care providers had an influence on patient behavior and health outcomes.
This potential influence was measured based on two research questions, one addressing
biometrics and one addressing medication adherence, pre and post intervention training.
Due to reliability and validity confounding factors, Research Question 2 on medication
adherence could not be answered.
The inconsistencies between the two data sets (completer and ITT) may be
attributed to the current study time frame and sample size limitations. Therefore, the
"implementation of a patient engagement provider training protocol" has more noticeable
effect on patients’ biometric outcomes with MetS within the completer set compared to
the ITT data set.
For research Question 1, analysis of completer and ITT data sets showed there
was no statistically significant difference of biometric outcomes, that means I failed to
reject the null hypothesis, and conclude that based on the current data and available
information there is no difference between the training and the non-training provider
groups.
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Chapter 5: Discussion, Recommendations and Conclusion
The purpose of this study was to determine whether integrative patient centered
training for health care providers influenced how patients understood and took care of
their personal state of health (patient engagement), thereby improving their health
outcomes. These health outcomes were measured through assessing bio data of patients
with metabolic syndrome (MetS). Specifically I analyzed their chronic disease biometrics
(triglycerides, fasting glucose, HbA1c, BMI, high-density lipoprotein, BP) and
medication adherence. In this chapter I explain the data capture challenges including
medication adherence analysis, data collection, and sample size attrition. Two areas of
significance are discussed regarding the outcomes data: a decrease in body mass index
and an increase in hyperglycemia. Demographics and the reasons why age ranges instead
of specific ages were used are explained. In addition, current trends regarding MetS,
provider training and education, and health care and delivery models are explored. I also
examined how these trends may lead to facilitating social change and its relationship with
the dynamic health care environment including how trends are both the drivers and
outcomes of ongoing social change. Limitations of this study are examined to better
understand the challenges and their impact. I address the latest research and lack of
research on the effectiveness and efficacy of training providers to improve patient health
outcomes. In conclusion I consider recommendations for further research and discuss
academic, research, and clinical opportunities around integrative patient centered care.
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Discussion: Data Capture, Significant Outcomes, Trends,
Social Change, and Limitations
Data Capture Challenges
This study had two research questions; Research Question 1 (RQ1): Is there a
difference in disease biometrics outcomes (blood pressure (systolic and diastolic),
triglycerides, body mass index (BMI), blood glucose (HbA1c and serum), and high
density lipoproteins) in patients with MetS following implementation of a patient
engagement provider training protocol; and Research Question 2 (RQ2), is there a
difference in medication adherence (EHR noted or reported by patient) in patients with
MetS following implementation of a patient engagement provider training protocol?
The capture challenges for RQ1 included multiple confounding factors such as no
control or incentives for facilitating patient return for appointments, and no control over
patients following up on appointments with a different provider. The capture challenge
for RQ2 was that the definition of medication adherence and the term “not taking” on the
electronic health record were not applied consistently across patient EHRs which in turn
negatively impacted outcomes data making it unreliable and invalid.
Research Question 1: Bio Data and Data Capture Challenges
Challenges in collecting patient data occurred at the 3-4 month point post
intervention training. One challenge was patients returning for a follow-up appointment
did not always return to the original provider group they were initially assigned, thus
making their post-intervention data invalid. Out of 91 patients, 11 saw a different
provider and their initial data capture had to be carried forward as intention-to-treat (ITT)
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group while disregarding their actual post intervention data, this supported the integrity
of the provider group while maintaining a higher sample size. Allowing this ITT group to
be created disallowed the attrition factor that would have eliminated 11 patients’ data or
having 8.27% of patient data unusable.
A second challenge centered on providers not ordering and collecting all research
biomedical labs previously captured for their baseline data. Triglycerides, fasting blood
glucose, HbA1c, HDL cholesterol, BMI, BP, and patient reported medication adherence
were initially captured. Attempts were made after 3 to 4 months post intervention to
capture the same data; however, the provider did not always request some of these labs,
or if labs were requested they were not always completed by the patient. This brought the
total number of patients with complete data (all biometrics from both the initial baseline
capture and post intervention capture) to 13 patients from provider training group and 30
from nontraining group.
A third challenge was that some patients did not return for a 3-month follow-up
appointment; therefore, no post intervention data were available. This lack of data and
high attrition rate had a significant impact on the ability to effectively analyze and
produce reliable and generalizable outcomes. However, creating the ITT data set and
bringing initial values forward allowed for the intervention group to remain at 37 and the
nonintervention group to remain at 54.
Research Question 2: Medication Adherence and Data Capture Challenges
At the onset of protocol development, the electronic health record medication
adherence note termed “not taking” was defined as the patient had chosen not to take the
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medication and was noncompliant with doctor’s orders. When post intervention outcomes
data were collected, I observed that the “not taking” EHR note for medications
sometimes referred to the medication not being taken were actually replaced by a similar
but not identical medication for the same condition, and all within doctor’s orders. Upon
further scrutiny and discussions with the physicians, I learned that “not taking” could
have various meanings. It could mean that the physician stopped the prescription or the
patient decided it was not indicated. For example, if it was a pain medication, the patient
took it only as long as needed; the patient could stop based on his or her own volition,
and it would later be discontinued by the physician in the EHR. Another example, a
patient was prescribed a different medication for the same condition due to various
reasons, and then the originally prescribed medication was listed as not being taken,
instead of stating that it was switched due to allergy, expense, not effective, or other
reasons that complied with doctor’s orders.
The original understanding and definition given for “not taking” and what was
discussed in Chapter 3, was, patients who decided not to take his or her prescribed
medication for his or her own reasons and without physician consent. If this definition
was consistent for every “not taking” note in the EHR medication note, then accurate data
could have been collected and it could have been discerned that medication not taken was
due to the patient making the decision without consult with his or her physician.
However, as described above, that was not the case.
Due to the inconsistent application of this definition for the medication adherence
dependent variable, criterion validity standards and construct validity were not met. This
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instrument of measurement was neither reliable nor consistent, and results would have
been skewed and/or completely inaccurate. Therefore, Research Question 2 and the
associated data were excluded from this study.
Significance of Outcomes Data
Intention to treat group (ITT). Only time had a significant effect on one
dependent variable (BMI). BMI decreased significantly over time in both the ITT
provider groups. The ITT data set demonstrated a slight decrease of BMI between the
intervention and control provider groups, but it was not statistically significant. In
addition, there was no statistically significant differences between within subjects (time)
or between subjects (groups) with the other dependent variables (disease biometrics).
The ITT provider training Group 1 (n = 37) demonstrated a statistically significant
(p < 0.05) decrease in BMI from 32.9 ± 7.2 Kg/m2 to 31.6 ± 6.8 (Table 7). The nontraining Group 2 (n = 54) demonstrated a statistically significant (p < 0.05) decrease in
BMI from 32.2 ± 6.7 Kg/m2 to 31.5 ± 6.3 Kg/m2 (Table 7). Although statistically
significant reduction in BMI was observed with ITT data, no statistically significant
difference was observed when comparing the training and non-training groups to assess
the effects of the training on patients’ BMI.
Completer Group. Time and training has a statistically significant p < 0.05 effect
on body mass index (BMI). BMI decreased significantly over time and but there was no
statistically significant difference between the training groups. Also, time has a
statistically significant p < 0.05 effect on fasting glucose in both provider groups.
Provider training Group 1 (n=13) demonstrates an increase in fasting glucose
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99.00 ± 12.84 mg/dl to 104.46* of ± 20.12 mg/dl (Table 6) and non-training Group 2
(n=30) demonstrates an increase in fasting glucose from 101.33 ± 13.40 mg/dl to 105.47*
± 18.60 mg/dl (Table 6) and (F (1,4) = 4.28, p < 0.05. It was noted that glucose increased
over time in the completer data set but not in the ITT data set. This fasting glucose
finding has no impact on the study due to no statistically significant differences between
study groups.
The completer data set shows there is no statistically significant difference p >
0.05 with BMI between provider training groups (n = 13). Within the provider training
Group 1 BMI decreases from (35.14 ± 7.86 Kg/m2 to 33.65 ± 7.62; Table 6) however,
with nontraining provider Group 2 there was no statistically significant (p > 0.05) change
(32.4 ± 6.62 Kg/m2 to 32.4 ± 6.5 Kg/m2; p = 0.469; Table 6). Therefore "implementation
of a patient engagement provider training protocol" has no statistical significance on
disease biometrics outcomes in patients with metabolic syndrome within the completer
data set.
Discussions on Outcome Findings
According to the annual American Health Association (AHA) assessment for
2015, hyperglycemia and waist circumference have been increasing and trending upward;
however, high triglycerides and blood pressure have been decreasing (Mozaffarian et al.,
2015). The hyperglycemic data from the AHA study aligns with these outcomes;
however, no details as to why this may be occurring have been determined. Factors that
may influence fasting glucose values and ability to compare values reliably, include not
knowing whether the patient did in fact fast and the time of day the labs were drawn.

66
Decreased BMI levels in both groups were most likely attributed to the treatment
approach for MetS patients, and in this case a specific focus on obesity and prediabetes.
All but two patients who had a decrease in BMI also had elevated HbA1c and/or elevated
glucose levels and were most likely being treated for prediabetes as well as obesity. The
two patients who did not have elevated HbA1c were borderline high glucose with 5.5
mg/dl, and for fasting glucose had levels 95 and 85 mg/dl. The standard treatments for
obesity and prediabetes include increased physical activity, diet low in sugar and fatty
foods, behavior and lifestyle changes, and in more resistant cases prescription weight loss
medication, weight-loss surgery, and diabetes medication (American Diabetes
Association, 2016; Mayo Clinic, 2016; NHLBI, n.d.). Patients who had elevated BMI
were most likely treated for prediabetes and were put on a more aggressive treatment
approach that may have led to a decrease in BMI for both groups.
Tae-Young Pak, Ferreira, and Colson (2016) found that BMI and incidence of
obesity are still increasing steadily in the United States and are population-wide issues.
However, certain demographics showed an increasing prevalence of obesity including
Hispanics, Blacks, elderly, and females (Campbell et al., 2016; Krueger, ColemanMinahan, & Rooks, 2014; Tae-Young Pak et al., 2016). Health care costs increased
significantly when BMI went from Class 1 obesity (30 ≤ BMI to < 35) to Class 2 and 3
(BMI ≤ 35) (Cawley, Meyerhoefer, Biener, Hammer, & Wintfeld, 2015). Keeping
obesity levels at Class 1 or lower where health care costs are not rising means lower
health care costs, less comorbid conditions, and fewer required medications (Cawley et
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al., 2015; Tae-Young Pak et al., 2016). A small decrease in BMI if held constant or
maintained would reduce health care costs and improve health outcomes.
Demographics
The demographics were analyzed by age range and not specific age based on
previous National Health and Nutrition Examination Surveys (NHNES) that included a
meta-analysis using this age range approach within the metabolic syndrome patient
population. To have comparable measures of age, age range was collected and assessed.
My data showed a downward trend in MetS symptoms from the 46-60 age range to the
61-75 year range, which was opposite from the National Health and Nutrition
Examination Survey (NHANES) 2002-2006 report, which indicated approximately 34%
of adults over 20 years met the criteria for metabolic syndrome and that it increased with
age and body mass index (Ervin, 2009). The reason for this difference may be my smaller
sample size, or that the MetS population may be reversing symptoms and becoming
healthier since 2009. However, a follow-up assessment by NHANES in 2015/2016 has
not been published.
Trends in Metabolic Syndrome
According to Aguilar, Bhuket, Torres, Liu, and Wong (2015), metabolic
syndrome prevalence from 2003 to 2012 has been stable. However, it is still a significant
issue on many fronts with 35% of adults and 50% of adults over 60 having MetS (Aguilar
et al., 2015). Possible improvements in MetS may be associated with greater patient
awareness and closer attention to lifestyle behaviors (Aguilar et al., 2015; BeltránSánchez et al., 2013). Patient awareness may be a result of health care providers taking
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more time to understand and collaborate with their patients on better lifestyle choices, or
patients independently choosing a healthier lifestyle. The reasons are difficult to identify.
Part of this difficulty may be attributed to pharmaceuticals that control symptoms like
high blood pressure and hyperglycemia, so lifestyle choices and behaviors may not have
changed but medication adherence may have improved. Also, not having reliable data to
accurately compare patient’s data to another’s is an ongoing challenge due to how MetS
symptom values are defined, how MetS is defined, and how improvements are defined
(e.g., does better health mean better bio values, better quality of life described by
patients, or a combination?).
Though improvement in MetS is the goal for a healthier population and reduced
health care costs, according to a NHANES report (2002-2006) 34% of the total
population still have MetS. The burden on patients and their quality of life, including
finances, still needs focused attention, research, and ongoing dynamic solutions. In
addition, the extreme burden on the U.S. health care system is requiring millions of
dollars not only to treat the MetS patients with medications and therapies but to bear the
burden of caring for those too sick to maintain an at-home sustainable lifestyle (BeltránSánchez et al., 2013; Cawley et al., 2015; Mozaffarian et al., 2015).
Trends in Training Providers
Provider-centric strategies. According to the American Health Association’s
2015 statistical update the following areas of provider centric strategies are an ongoing
focus in the efforts to prevent and treat cardiovascular and associated comorbid
conditions such as diabetes, obesity, hyperglycemia, low HDL, and high triglycerides,
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(those with MetS and at greater risk of serious and costly chronic conditions)
(Mozaffarian et al., 2015). These areas are defined by the Institute of Medicine (IOM)
using six domains, and include shaping health care systems to incentivize and facilitate
provider efforts to improve not only the health factors (e.g., bio markers of MetS) but
also the health behaviors of their patients. The IOM reports that supporting healthy
behaviors such as nutrition and increased physical activities is essential especially with
those at greater risk of developing a more serious chronic conditions, such as those with
MetS (Dickerson et al., 2011; Mozaffarian et al., 2015;Spieker et al., 2015). Training
health care providers in understanding and applying patient centered approaches to
patient care can be part of this health care system’s approach to reach its goals of
improved patient wellness.
Training within academia. Patient centered team based care with a focus on
quality and safety has been a dedicated movement within the health care industry and
highlighted by the Institute of Medicine Report Crossing the Quality Chasm (Institute of
Medicine, 2001). This report helped drive improvement within the medical education
system and development of Entrusted Professional Activities (EPA) that translate
competencies into medical practices. It takes into account knowledge, skills and attitudes
across the work a family physician performs and the competency domains they are
required to integrate (AMA. n.d.; Bhuyan et al., 2014; Shaughnessy et al., 2013). It also
aligns with follow-on continuing education and keeping the provider aware of and
integrating the latest needs in health care and delivery. This focused structured training
includes flexible competency-based pathways, teaching new content in health systems
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sciences, working with health care delivery systems in novel ways, making technology
work for learning, envisioning master adaptive learner, and shaping tomorrow’s leaders;
it encompasses concepts of team-based care, patient provider engagement and efficiency
of systems and assumes another building block to provider’s initial and ongoing
education (AMA, n.d.; Bhuyan et al., 2014; Shaughnessy et al., 2013).
Efficacy of provider training to improve health outcomes. Training health care
providers is used successfully in other areas of patient population’s treatment and care
but limited research is found within the MetS population. Patient populations such as the
disability population (Iezzoni & Long-Bellil, 2012); mental illness (Byrne, Willis, Deane,
Hawkins, & Quinn, 2010; Caruso et al., 2013); pediatrics (Jacobson & Gance-Cleveland,
2011; Xiang, Wethington, Onufrak, & Belay, 2014); and trauma patients (Green et al.,
2015) showed improvements in health conditions where physicians were trained in more
patient centered counseling approaches. In addition, a study with fibromyalgia patients
demonstrated providers trained in shared decision making (SDM) had significantly better
provider patient engagement, however health outcomes did not show improvement
(Bieber et al., 2006).
Though not working with specific MetS population, a recent study by the military
utilized physicians already trained in patient centered medical home approaches who
focused on obesity prevention in military populations (pregnant women and those post
boot camp) which showed a positive trajectory of patient health outcomes, however the
final study is not complete (Spieker et al., 2015). Another study by Ampt et al. (2009)
discussed provider education and attitudes that may have impacted lifestyle risk factors.
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Specifically, attitudes of practitioners were described as having an influence over why
they decided to assess their patients for conditions such as alcoholism. Some providers
felt certain assessments were to be done only during a formal health check, so many
health components were not even considered during other clinical appointments. Also
diet and exercise were sometimes inferred by patient appearance and only addressed if
overweight. In addition the practitioner’s feelings regarding their effectiveness and
influence over their patients were considered an attitudinal factor that might impact the
patient’s motivation towards lifestyle changes (Ampt et al, 2009).
Specific studies with chronic disease and/or MetS patient populations included
provider education that focused on including verbal, visual, and written approaches
which increased the ability to more effectively communicate with their patients (Towner,
2008). One of the most promising chronic illness studies focused on physician practices
and medical home models. The study was based on three national surveys from 2006 to
2013 and included 538 medical groups and independent practice associations; it stated
increasing practices’ ability to engage patients and their families in their own care may be
fundamental to advancing patient engagement (Wiley et al., 2015). Patient engagement
was my research study’s focus, however the outcomes did not reject the null hypothesis.
Other research supports the need for increased provider’s ability to improve their
patients’ engagement (Ampt et al., 2009; Spieker et al., 2015; Wiley et al., 2015). This
research supports my premise around improving lifestyle behaviors and the patients’ state
of health through more patient centered approaches in treatment and care.
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Shared Decision Making (SDM) is a term often used in association with patient
centered care, patient provider engagement, and other practices that focus on the
relationship between the provider and patient (Tapp et al., 2014). It is found that
providers and patients may have different goals for the patient’s treatment and care, and
without effective collaboration between provider and patients, low or no SDM can lead to
inadequate chronic pain management (Frantsve & Kerns, 2007; Tilburt et al., 2014).
The concept and practice of patient centered care is supported through multiple federal,
state, and local medical and health care associations and their initiatives and policy.
These initiatives include the AMA’s new resolutions to promote evidence based
lifestyle medicine and interventions in treatment of disease as the first primary mode of
prevention, and a focus on the need for patient centered health care provider training
(AMA, n.d.). The National Academy of Sciences has five core competencies every
physician should incorporate: provide patient centered care, work in interdisciplinary
teams, apply quality improvement, and utilize informatics (Summit, Greiner, & Knebel,
2003). There are movements and programs throughout the U.S. and other countries
utilizing numerous methods to advance the patient centered care model. This patient
centered model and approach, though not standardized in the industry yet, is being
promoted as a worthwhile model to implement into practice and integrate into the health
care delivery payer models. The challenges around efficacy and effectiveness includes
producing evidence-based research showing the benefits to health outcomes and reduced
costs across systems.
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In conclusion on trends in training, a meta-analysis that assessed the value of
medical provider training showed that patient centered training was effective in
improving providers’ patient centered skills (Dwamena et al., 2012). The effect on patient
satisfaction and healthy behaviors were mostly positive, however health outcome
improvements were not consistent. These inconsistent “improved outcomes” were a
running theme within understanding the effects of patient centered care and provider
training overall, and support justification of continued research (Ampt et al., 2009; Wiley
et al., 2015; Spieker et al., 2015; Towner, 2008).
Trends in Health Care and Delivery Models
Trends in health care delivery models have emerged from both a grassroots
patient/consumer driven demand and provider demand to practice more satisfying
medicine; and a top down policy driven trend facilitated by the Accountable Care Act
(ACA), AMA, Healthy People 2020, National Prevention Strategy, and Institute of
Medicine’s Crossing the Quality Chasm. The ACA is facilitating initiatives to improve
patient experience, health of the population, and reducing costs per capita, called the
accountable care organization’s triple aim focus. The ACA also includes promotion of
the medical home model that emphasizes coordination of care and patient satisfaction
(Daly, 2013).
The National Prevention Strategy, Healthy People 2020 and the Institute of
Medicine Crossing the Quality Chasm lay out goals and criteria to get the people of our
nation healthier and happier; while conveying the urgency to make changes due to the
epidemic of chronic illness which does not discriminate between race, gender, and age
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(Healthy People 2020, 2014; Health and Human Services, 2016; Institute of Medicine,
2001). In addition the continued increase of health care costs impact our nation, our
economy, our businesses, our individual expenses, and quality of life (Daly, 2013). The
CDC stated the rate of chronic disease such as obesity, cardiovascular, stroke, and cancer
is increasing and accounts for 75% of our nation’s 2 trillion spent on health care. This
spending makes chronic disease the lead factor in current health care expenditures, in
front of technology, prescription drugs and administrative costs (CDC, 2011; Kaiser,
2012). The above trends reflect both the outcomes and the drivers of social change in our
dynamic health care environment; from patient and provider satisfaction, to decreasing
health care costs, to federal policy development focused on disease prevention, patient
centeredness, and equitable treatment reimbursement.
Social Change
This study has a critical mission, to assess the effects of patient centered
integrative provider education and clinical practice application with their MetS patients
through identifying if training influenced patient engagement behaviors and thereby
medication adherence and health outcomes. It provides a basis for an innovative,
effective inspiring model of health care and delivery based on promoting healthy provider
patient relationships in order to facilitate patient engagement and gain positive health
effects. However what may faciliate the greatest social change is simply working towards
understanding what matters most to patients in order to motivate positive lifestyle
behaviors and allowing providers the time and reimbursement to practice patient centered
health care.
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Training health care providers specifically in the conceptual and practical
application of integrative patient centered engagement can in turn help the provider
maintain a satisfying practice. As this component of health care and delivery is
understood, delineated, and correlated with improved patient engagement it may be an
additional practice that gives providers requisite skills to empower their patients towards
motivated self health care and medication adherence and the provider towards a more
fulfilling practice. This approach to understanding and incorporating new health care
practices is a paradigm shift in the U.S. and represents social change.
Overall this study reflects social change on two fronts, positively influencing
quality of life for both the patients and providers. If patients’ overall health improves and
there is less need for medications, emergency procedures, and chronic disease care then
health care costs for these conditions will presumably decrease. Social change for this
research revolves around patients feeling better and becoming healthier based on the
providers’ ability to engage their patients and influence positive behavioral changes.
Specifically, health care training that provides conceptual and practical application of
integrative patient centered engagement tools may support individual patient engagement
health behaviors that in turn may positively impact MetS symptoms. These social
changes have the potential to improve health outcomes, reduce chronic disease, decrease
health care spending and improve the overall life of those suffering with MetS and those
providing the care.
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Limitations
The quality of bio data outcomes may have been impacted by multiple factors to
include labs not being taken at the same time of day and under the same conditions such
as fasting. Medication adherence data were found to be unreliable due to the original
definition and criteria of “not taking” on the electronic health record not being consistent
across MetS patient EHRs. This significant discrepancy within the medication adherence
measurement instrument necessitated Research Question 2 and its data to be excluded.
The sampling size significantly diminished from a 515 to 91patient data due to
initially filtering MetS patients on three of the six dependent variables (triglycerides,
HDL, and BP), when first assessing the sample environment; then filtering utilizing the
remaining three variables (fasting glucose, HbA1c and BMI) to obtain the research
sample. In addition, capturing post intervention data were limited by patients not coming
back for their follow-up appointments, not getting provider requested labs, and patients
not having their follow-up clinical visit within their original provider group. The sample
size did not meet the minimum requirement of 125, even with establishment of the ITT
data set.
Another limitation revolved around the term patient engagement and the various
definitions still used within the health and medical industry. Even though this research
was based on the combined definitions from the Agency for Healthcare Quality and
Research (AHQR) and Simmons et al, (2014)’s systematic review study, the literature
review and in depth research had to involve numerous other related terms in order to
capture most of the research around this topic. The challenge included filtering out data
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and information that did not meet definition criteria, and extrapolating from the literature
pertinent information necessary for understanding and performing this research.
In summary, biometric limitations included knowing if a patient had fasted and
performed labs at a certain time of day, which may be a challenge for any similar
research protocol. Filtering sample size by all variables under study is a process that can
be performed in the future for more precise initial sample data numbers. Also,
understanding how medication adherence is defined and understood across all patient
medical records and medical scenarios would facilitate greater use of this impactful
health factor. Overall, the most challenging limitations around this patient engagement
study was defining and utilizing the term patient engagement. Further refinement and
research must be conducted in order to establish a consistent generalizable term that can
be used reliably across the industry in research, academia, and clinical practice.
Recommendations
Recommendations for further research around patient engagement and medication
adherence are indicated from this study. Although my medication adherence research
could not be utilized, the current negative impact on health and finances due to
medication noncompliance strongly suggest further research is warranted. In addition,
based on my review and research of patient engagement and provider training,
specifically within the MetS patient population, there are significant health benefits and
knowledge to be gained from follow-on research.
The population’s health and wellbeing in the U.S. is benefiting from this
integrative patient centered care movement and paradigm shift from a disease centric
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reactive health care system to one based on prevention, whole-person health, and
collaboration. Metabolic syndrome patients engaging in their care and healthy lifestyle
choices is essential to improved health and better quality of life; and providers practicing
compassionate effective care will continue to be a contributing factor. As the Patient
Centered Outcomes Research Institute and the Agency for Healthcare Research and
Quality develop models, frameworks, and approaches that align provider training with
reliable and patient centered approaches, follow-on research can be conducted producing
evidence-based outcomes that will be understood and incorporated throughout the health
care system. Through incorporating evidence based models of integrative
patient/family/community centered care, improved population health and exceptional
individual quality of life can be achieved.
Conclusion
This study assessed the effects of a patient engagement provider training protocol
on patient engagement and whether there was an effect on patient health outcomes and
medication adherence. Due to validity and reliability issues medication adherence could
not be assessed. Two groups of patients were compared, those that had clinical visits with
providers trained on integrative patient centered care (intervention group), and providers
not trained on integrative patient centered care (control group). Two areas of literature
were used to define patient engagement for this research. First, patient engagement
defined by the Agency for Healthcare Quality and Research (AHQR), “an ongoing
process in which patients take an active role in their own healthcare” and involve factors
including “personal skills, motivation, and behaviors-affect an individual’s ability to
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effectively engage in care” (AHRQ, 2011, p.1). Second, Simmons et al. (2014) used the
definition in their systematic review of clinical trials on patient engagement as (a)
understanding the importance of taking an active role in one’s health and health care; (b)
having the knowledge, skills, and confidence to manage health; and (c) using knowledge,
skills and confidence to perform health-promoting behaviors (p. 3). Together these
definitions shaped and drove the research.
There are many approaches and techniques used to describe new and old ways to
develop “bedside manner” in order to improve the relationship between provider and the
patient to support patients in their lifestyle behavior choices. Patient centered techniques
in the field include: shared decision making (SDM), SHARE by NCQA, motivational
interviewing, facilitating congruence, collaborative care, patient provider symetry,
participatory medicine, relationship centered care, building healing relationships, patient
centered care, teach back, health literacy awareness, and others (Barello et al., 2012;
Bertakis, Klea, 2011; Cox, 2011; Gionfriddo et al., 2014; Jackson, Tucker, & Herman,
2007; Williams et al., 2000). There are multiple models of health care and delivery from
which to incorporate these techniques such as: patient centered medical home (PCMH),
accountable care organizations (ACO), community centered health homes, medical/health
homes and others in our forward progressing health care arena (Daly, 2013; Peek, 2010;
Rittenhouse et al., 2010). Regardless of the integrative model employed or patient
centered approach used, at the most fundamental level it is beneficial for providers to
strive to know their patient and to know themselves for best outcomes.
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Provider training was given to promote health care providers’ ability to facilitate
self-healthy behaviors (patient engagement) with their patients; such as better nutrition,
exercise, stress management, restorative sleep, pursuit of happiness and medication
adherence (AHRQ, 2011; Brunton, 2011; Chisholm-Burns & Spivey, 2012; Cox, 2011;
Engel, 1977; Guarneri & Tager, 2014; Khanna et al., 2012; Simmons, et al., 2014;
Williams et al., 2000). Eventhough there was no statistically significant relationship
between provider groups (training/non-training) and patients’ immediate health results,
many integrative patient centered skills were taught and potentially practiced by the
providers, yielding promising favorable health outcomes.
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Appendix A: Integrative Healthcare Patient Centered Patient Engagement Training

(Color divides three training sections taught during three separate dates)
1. Integrative Patient Centered Healthcare a. Escape Fire Film
b. Industry definitions (Clinical, Academia, Research)
c. NOVA Medical Group definition
2. Patient Engagement
a. Definitions in industry
b. Training definition
3. Health Literacy
a. Defined
b. Necessity (Culturally/Linguistically)
c. Current Issues/Challenges: Health Disparities
4. Mission, Vision, Values
a. Yours
b. Company’s
c. Optimal
5. Your Patient Engagement Style
a. Emotional Intelligence
i. Your role in prevention and health promotion (knowledge &
attitude)
ii. What you do well
iii. What you want to do better
b. Style
i. Conscientious
ii. Direct
iii. Influencer
iv. Steadiness
c. Building Awareness
i. Building Healing Relationships
ii. Motivational Interviewing
iii. SHARE Approach
d. Limitations, Challenges, Obstacles
i. Enough time with patients
ii. Clinical inertia
e. What Motivates you
i. Job well done
ii. Pay incentives (pay for performance, time off)
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iii. Patient feedback (to provider and public/work recognition)
f. Your optimal Patient Relationship
6. Patient Intake & Application
a. Questions & Comfort Level (lifestyle, intimacy, nutrition, family
health history/relations)
b. Shared Decision Making (SDM)
c. Educating /Motivating Patient (understanding main issue, treatment
& personal goals, follow up at 1-3 months).
d. Electronic Health Record Integration
e. In house referrals and complementary therapists
f. Working as an integrated team (processes for)
g. Workflow – Bringing it all together
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ANGELA MCCONNELL
CURRICULUM VITAE
Q Integrative Healthcare LLC &
Northern Virginia Veterans Association, 501(c)3
Angela@IntegrativeHealthVA.com & President@NovaVets.org

OWNER / CONSULTANT
COMMUNITY SOLUTIONS
Developing & Collaborating to Establish Patient Centered Healthcare
Innovative business leader experienced in implementing collaborative community health
partnerships and integrative patient centered care programs and policies for the healthcare
community. Experience includes working with public/private medical centers,
Veteran/military programs and initiatives, academic institutions and information
technology systems.

Leadership experience across all levels of healthcare and military with emphasis on
management, patient centered care, quality, safety, workflow efficiency and multi-site
operations. Expert in identifying gaps and needs in healthcare, understanding how to
educate and build upon systems strategy by leveraging resources and capabilities.
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Lead Industry Speaker ≈ National Summits, Hospitals, DoD Centers of
Excellence, Chambers of Commerce, Congressional Councils, Veterans Service
Organizations, Departments & Associations & Public Health Initiatives

Chairperson ≈ Prince William Chamber of Commerce Health Council
Board of Directors / Advisor ≈ Providing insight and expertise to agencies
and organizations on veteran and health-centric issues

President/CEO and Founder ≈ Northern Virginia Veterans Association

PROFESSIONAL EXPERIENCE
Q Integrative Healthcare LLC Owner, Woodbridge, VA,
2009 – Present.
Integrative Healthcare subject-matter expert providing consultation and support.
Strategic development of collaborative community-wide health/medical/wellness
partnerships. Consulting, creating and implementing integrative healthcare
infrastructure, programs and policies. Utilizing leading-edge research, analytics, and
innovation to create efficient collaborative health systems focusing on improving health
outcomes, reducing costs and sustaining a culture of continuous improvement.
Leads healthcare stakeholders in resource sharing and partnerships as
Chairperson, Prince William Chamber Health & Wellness Council. Focused is
placed on local, state and federal policy issues, workplace wellness and
healthcare reform. Stakeholders include hospital systems, medical providers,
insurance companies, employers and employee-consumers.

104
Partnered with ABC 7 and United Way on multi-media Veterans Hiring
Campaign. Provided support in developing, organizing and networking nonprofit,
government & private sector organizations to determine employment challenges
in order to provide a continuum of services in support of Veteran/family success
across National Capitol Area.
Developer and instructor of continuing education on integrative healthcare and
community collaboration topics that include: integrative healthcare models,
integrative patient centric practices, trauma/post traumatic stress disorder,
military culture/ medical resources, workplace wellness and community
partnerships/networks.

Northern Virginia Veterans Association (Founder)
President/CEO (Jan 2015 – Present)
Local Resources to Support Our Local Veterans. Founded and began developing
NOVA Veterans in 2013. It has a distinct and necessary mission being a hands-on, nonprofit that connects veterans & military families, at no cost, to a vast system of
community resources addressing needs to support & improve their quality of life. This
service organization is different such that it provides a comprehensive continuity of
support, follow-up and case management. It is not a referral agency nor navigation
service, but a quality control organization that coordinates support through select
trusted partners. Through this structure our partners connect and learn about each other,
breaking down the silos in order to build a responsive, efficient and caring community.
Founded because no other organization was providing guidance, comprehensive
support and case management through this complex and confusing web of
services
Nationally almost half of veterans surveyed didn’t know how to get the services
and benefits they deserve and have earned
22 Veterans a day commit Suicide
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On-going veteran & community awareness to action campaigns for Northern Virginia, to
provide information and resources: 1) Determining local veteran resources, 2) Identifying
local veteran needs and creating solutions, 3) Providing a rally point for veteran
volunteers to support other veterans in our local community, 4) Performing widest
veteran outreach & support. www.novavets.org

Consultation & Capture Management Medical/Healthcare
(2012/2013)

Provides comprehensive contract management capture, proposal strategy, and
comprehensive subject matter expert support for Applica Solutions (SDVOSB).

New Business Consulting / Business Development
(2011/2012)
Provides innovative policy and program infrastructure for the National Aesthetic
Accreditation Agency, the first medical aesthetic accreditation agency. Integrates new
state regulations to support legal, safe, quality standards for all medical aesthetic
practices. Incorporates transparent competitive marketing with a patient centered focus.

Counter Terrorism/Force Protection Reserve Officer (June
1994 – July 2009 retired) Major, United States Air Force Europe, Ramstein
Germany. Provided integrated, multi-discipline intelligence to satisfy warfighter
requirements for all phases of military operations. Monitored and analyzed activities in
conjunction with military/political crisis situations. Developed strategic mission-essential
threat assessments and plans, in partnership with civilian & military leadership.
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Project Manager FDA (May 1991 – May 1993) Ebon Research
Systems: Food and Drug Administration, Laurel MD. Managed and lead thirty plus
biomedical research employees in new bio-hazardous facility. Prepared and
implemented all standard operating procedures covering personnel, biohazard
regulations, research materials and equipment. Ensured research protocols, personnel,
and facility complied with federal, state and local laws, policies and regulations.

Manager/Technologist – U.S. Army Active Duty (January 1987 – May 1991)
Sergeant, Walter Reed Army Medical Center / Armed Forces Institute of Pathology
Washington D.C., biomedical research support. Uniformed Services University of the
Health Sciences Bethesda MD, managed critical research division. Practiced and
directed technologists on procedures for research protocols. Supported and educated
investigative staff and medical student body in medical / surgical procedures and
techniques. (Inactive Ready Reserves June 1991-May 1994).

EDUCATION
Walden University, PhD Health Administration Candidate, 2016
Ohashiatsu Institute, Shiatsu Acupressure Graduate, Nov 2004
Troy University, Masters of Public Administration, Dec 1999
University of Maryland, B.Sc. Microbiology, July 1992

BOARD OF DIRECTORS & PROFESSIONAL ASSOCIATIONS
George Mason University College of Health and Human Services Advisory
Board
Federal Congressional Health Advisory Council & Veterans Advisory Council
Member
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Board of Director Virginia Alliance of Information and Referral Systems
Board Veteran Advisor to the Prince William County Government Area on
Aging
Military Officer Association of America & Reserve Officers Association
Prince William Chamber of Commerce: Health & Wellness Council,
Government Affairs, Veterans Council, Nonprofit Council

AWARDS AND DECORATIONS
NOVA Veterans Assoc., Prince William Living Giving Back Award – 1st
Runner Up 2015
2015 Catherine Spellane Citizen of the Year, Dale City Civic Association
Prince William Chamber of Commerce Business of the Year 2013
President’s Volunteer Service Award from the President’s Council on Service
and Civic Participation 2009
USAFE Outstanding Air Reserve Field and Company Grade ISR Officer of the
Year (Jan 2007, Jan 2006, and Jan 2003) – Awarded for outstanding
leadership and exemplary improvements to war fighting capabilities
Meritorious Service Medal – Awarded 9 Sept 2005 for distinguished
meritorious service as Counter Terrorism Analyst, United States Air Forces in
Europe Theater Air and Space-operations Center, Germany

CLUBS/ACTIVITIES
Team Red White & Blue (Veterans/Military Health and Fitness) & Ride to
Recovery (R2R)
Ballroom / Latin Dance
Bikram Yoga / Triathlons
Rolling Thunder Rider
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SPEAKER, VOLUNTEER, EDUCATOR, INNOVATOR
Monthly speaking engagements to include: 2016, Area on Aging, veteran
panels, healthcare panels, Prince William Chamber Medical Panel on
Innovation (July 2015)
Military Culture & Healthcare Resources Training – Hospitals, Clinics, Medical
Providers
Association for Defense Communities National Summit - Expert Panel
Speaker on Medical Community Partnerships (June 2014);
Chamber of Commerce Speaker and Moderator multiple events (2011Present)
Wounded Warrior Mentor Program: Serving wounded warriors and their
families, Fort Belvoir, Quantico, Walter Reed Bethesda (Jan 2011 - Present)
DCoE Psychological Health & Traumatic Brain Injury: Air Force Reserve,
briefed and advised leadership on Integrative Healthcare and its
comprehensive application and benefits to the military (July 2009)
Walter Reed Army Medical Center CAUSE/TOR contract coordinator for
Mologne House Grant Program: Hiring, training and providing credentialed
complementary practitioners for military outpatients and family members (Oct
2008 – Oct 2009)
Army’s Force Health Protection Conference: Developed and presented
information and education brief on The Benefits of Shiatsu/Acupressure
Integrative Complementary Therapy for Post Traumatic Stress Disorder
(Kentucky 2007).

